data_1ln6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ln6 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.525 3.306 0 CA-C-O 116.527 -1.701 . . . . 0.57 111.279 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . 0.286 . . -57.24 -82.45 0.01 OUTLIER 'General case' 0 C--O 1.262 1.734 1 O-C-N 131.749 5.656 . . . . 0.57 108.15 176.016 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -33.41 -49.35 0.28 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 119.166 3.024 . . . . 0.57 119.166 169.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 1.227 ' OH ' ' HG2' ' A' ' 296' ' ' LYS . 1.0 OUTLIER -48.81 -61.8 1.85 Allowed 'General case' 0 N--CA 1.425 -1.68 0 C-N-CA 125.51 1.524 . . . . 0.57 107.826 176.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.4 ' C ' ' SD ' ' A' ' 44' ' ' MET . 7.8 tmm? -65.49 -55.9 15.34 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 123.237 1.494 . . . . 0.57 111.302 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -37.63 -37.7 0.23 Allowed 'General case' 0 CA--C 1.476 -1.873 0 C-N-CA 129.299 3.04 . . . . 0.57 116.791 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.1 mt -121.31 -66.67 1.03 Allowed 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 125.241 1.416 . . . . 0.57 111.667 174.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 mp -62.05 -42.53 99.28 Favored 'General case' 0 CA--C 1.602 2.967 0 CA-C-N 113.803 -1.544 . . . . 0.57 109.021 -158.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.5 mm -101.95 15.15 5.43 Favored 'Isoleucine or valine' 0 C--N 1.381 1.941 0 C-N-CA 118.299 -1.36 . . . . 0.57 114.335 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.1 mmm -81.26 70.57 8.13 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 125.81 2.719 . . . . 0.57 106.328 154.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 tp -174.86 -45.88 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.381 1 CA-C-N 105.72 -5.218 . . . . 0.57 104.39 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.588 ' O ' ' CG ' ' A' ' 56' ' ' PHE . . . -54.04 -61.15 7.44 Favored Glycine 0 N--CA 1.501 3.029 0 O-C-N 118.357 -2.714 . . . . 0.57 111.493 161.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 1.005 ' CD1' ' CD1' ' A' ' 56' ' ' PHE . 42.5 m-85 -72.42 136.93 80.99 Favored Pre-proline 0 C--O 1.198 -1.617 0 N-CA-C 105.431 -2.062 . . . . 0.57 105.431 158.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 56' ' ' PHE 0.443 93.0 Cg_endo -94.05 -3.62 42.04 Favored 'Cis proline' 0 C--N 1.387 2.585 0 N-CA-C 117.5 2.077 . . . . 0.57 117.5 -20.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.3 mt -46.95 -65.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.422 3.733 0 CA-C-N 120.46 1.482 . . . . 0.57 113.642 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 59' ' ' LEU . 0.7 OUTLIER -55.91 -51.18 68.53 Favored 'General case' 0 C--N 1.392 2.413 0 CA-C-N 112.342 -2.208 . . . . 0.57 110.656 166.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 1.005 ' CD1' ' CD1' ' A' ' 52' ' ' PHE 0.34 6.0 m-85 -40.71 -66.41 0.33 Allowed 'General case' 0 CA--C 1.592 2.562 0 CA-C-N 114.897 -1.047 . . . . 0.57 111.046 -172.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.9 tp -62.01 -53.76 51.04 Favored 'General case' 0 C--O 1.255 1.381 0 O-C-N 119.521 -1.987 . . . . 0.57 110.175 176.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.323 0.8 OUTLIER -71.56 -3.06 19.25 Favored 'General case' 0 N--CA 1.405 -2.688 0 O-C-N 125.709 1.881 . . . . 0.57 115.373 -169.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 55' ' ' ASN . 3.5 tp -63.85 -41.21 97.85 Favored 'General case' 0 CA--C 1.586 2.34 0 N-CA-C 100.61 -3.848 . . . . 0.57 100.61 173.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -68.99 -43.32 75.1 Favored 'General case' 0 CA--C 1.588 2.409 0 O-C-N 126.897 2.623 . . . . 0.57 106.316 -165.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.839 ' O ' ' CG1' ' A' ' 318' ' ' VAL . 74.0 t -52.71 -37.21 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.656 0 O-C-N 127.983 3.302 . . . . 0.57 110.878 176.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.7 p -95.18 -81.37 0.4 Allowed 'General case' 0 CA--C 1.577 1.998 0 C-N-CA 115.499 -2.481 . . . . 0.57 113.365 -171.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . 0.389 2.6 m -45.71 -65.84 0.16 Allowed 'Isoleucine or valine' 1 N--CA 1.541 4.084 0 CA-C-N 112.465 -2.152 . . . . 0.57 115.408 -151.239 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 36.5 87.08 0.01 OUTLIER 'General case' 0 C--N 1.386 2.163 0 O-C-N 126.077 2.111 . . . . 0.57 115.648 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 40.07 42.28 1.1 Allowed 'General case' 0 C--O 1.211 -0.922 0 CA-C-O 123.516 1.627 . . . . 0.57 110.66 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.533 ' NZ ' ' O ' ' A' ' 77' ' ' LEU . 62.7 mttm 49.31 82.84 0.04 OUTLIER 'General case' 0 N--CA 1.387 -3.592 0 CA-C-N 112.555 -2.111 . . . . 0.57 110.224 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -35.91 -69.11 0.11 Allowed 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 117.568 2.432 . . . . 0.57 117.568 -152.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -133.85 93.25 3.08 Favored 'General case' 1 C--N 1.447 4.828 0 N-CA-C 102.52 -3.141 . . . . 0.57 102.52 178.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.34 154.64 40.01 Favored 'General case' 0 CA--C 1.597 2.753 0 CA-C-N 110.819 -2.9 . . . . 1.2 104.631 162.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 m -131.38 53.77 12.61 Favored Pre-proline 0 N--CA 1.517 2.92 0 C-N-CA 126.857 2.063 . . . . 0.57 113.546 -3.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -95.12 -170.39 0.19 Allowed 'Trans proline' 0 C--N 1.412 3.881 0 N-CA-C 105.919 -2.377 . . . . 0.57 105.919 160.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.996 ' CB ' ' CB ' ' A' ' 310' ' ' ASN 0.483 0.8 OUTLIER -34.11 84.42 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 O-C-N 127.566 3.042 . . . . 0.57 115.465 170.526 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.501 ' HB2' ' HE1' ' A' ' 309' ' ' MET . 0.3 OUTLIER -161.62 29.42 0.13 Allowed 'General case' 0 CA--C 1.502 -0.891 1 O-C-N 131.342 5.401 . . . . 0.57 106.375 164.498 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -31.19 -54.79 0.23 Allowed 'General case' 0 CA--C 1.596 2.721 0 C-N-CA 129.025 2.93 . . . . 0.57 115.712 -166.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.4 pt -51.85 -55.02 10.73 Favored 'Isoleucine or valine' 0 C--N 1.393 2.483 0 CA-C-N 108.563 -3.926 . . . . 0.57 108.043 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mt -73.09 -11.4 60.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.591 -1.318 . . . . 0.57 113.027 -171.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.533 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -79.46 -54.31 6.04 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 116.08 -2.248 . . . . 0.57 105.302 169.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -168.65 130.98 1.34 Allowed 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 129.092 2.957 . . . . 0.57 105.472 170.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 81' ' ' VAL . 1.8 tp -74.65 -31.21 61.87 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 129.995 3.318 . . . . 0.57 115.501 39.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.514 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . -49.91 76.65 0.0 OUTLIER 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 119.893 3.294 . . . . 0.57 119.893 -171.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' LEU . 67.4 t -143.95 -41.43 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.758 0 CA-C-O 125.716 2.674 . . . . 0.57 110.764 166.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.45 -82.65 0.15 Allowed 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 111.197 -2.728 . . . . 0.57 105.079 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -15.39 -54.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 118.963 2.949 . . . . 0.91 118.963 159.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.1 tp -49.17 -49.5 42.3 Favored 'General case' 0 C--N 1.414 3.393 1 O-C-N 129.179 4.049 . . . . 0.57 114.476 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . 0.295 8.8 t80 -75.85 -20.56 58.02 Favored 'General case' 0 CA--C 1.553 1.086 1 CA-C-N 107.05 -4.614 . . . . 0.57 112.28 -173.998 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.498 ' SD ' ' HA ' ' A' ' 296' ' ' LYS . 31.6 mtt -60.79 -35.11 75.63 Favored 'General case' 0 C--N 1.371 1.506 0 CA-C-O 126.246 2.927 . . . . 0.57 110.927 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.07 -33.46 63.88 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.406 0 CA-C-N 108.422 -3.99 . . . . 0.57 108.91 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -159.39 79.24 0.74 Allowed 'General case' 0 N--CA 1.518 2.939 0 C-N-CA 116.166 -2.213 . . . . 0.57 110.375 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.83 -139.53 17.16 Favored Glycine 0 C--N 1.375 2.738 0 CA-C-O 122.553 1.085 . . . . 0.57 115.499 -21.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 32.3 -122.83 0.23 Allowed Glycine 1 CA--C 1.625 6.95 0 CA-C-N 113.091 -1.554 . . . . 0.57 112.645 160.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -59.11 -55.89 29.27 Favored 'General case' 0 C--O 1.19 -2.048 0 CA-C-O 124.033 1.873 . . . . 0.57 109.727 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.5 m -46.85 -26.77 1.04 Allowed 'General case' 0 N--CA 1.413 -2.29 0 C-N-CA 129.407 3.083 . . . . 0.57 113.576 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 m -156.85 11.79 0.24 Allowed 'General case' 0 CA--C 1.586 2.336 0 C-N-CA 114.208 -2.997 . . . . 0.57 112.036 -172.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 1.145 ' CA ' ' HB3' ' A' ' 98' ' ' SER . 2.6 m -168.75 45.42 0.04 OUTLIER 'General case' 0 C--O 1.258 1.548 0 C-N-CA 115.225 -2.59 . . . . 0.57 106.206 -173.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.1 tt -166.32 -54.41 0.03 OUTLIER 'General case' 0 C--O 1.188 -2.174 0 O-C-N 118.567 -2.583 . . . . 0.57 106.098 169.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -71.25 -53.92 12.68 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 109.101 -3.681 . . . . 0.57 107.971 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 1.061 ' O ' ' HB2' ' A' ' 98' ' ' SER . 6.2 m -151.71 104.17 3.01 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 115.431 -2.224 . . . . 0.57 105.117 -169.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 1.145 ' HB3' ' CA ' ' A' ' 94' ' ' THR . 3.7 t 146.8 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 120.28 1.4 . . . . 0.57 111.848 -168.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.452 ' HG ' ' SD ' ' A' ' 288' ' ' MET 0.261 0.2 OUTLIER 97.24 -50.61 0.01 OUTLIER 'General case' 0 C--N 1.384 2.1 0 C-N-CA 127.604 2.362 . . . . 0.57 108.298 -176.375 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.59 153.11 48.65 Favored 'General case' 0 CA--C 1.594 2.671 0 N-CA-C 100.741 -3.8 . . . . 0.57 100.741 158.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.669 ' C ' ' HB3' ' A' ' 103' ' ' PHE . . . -93.52 -169.44 38.81 Favored Glycine 1 CA--C 1.581 4.159 0 C-N-CA 130.454 3.883 . . . . 0.57 104.232 -14.022 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 1.514 ' CB ' ' HB2' ' A' ' 103' ' ' PHE 0.426 2.3 m-85 -48.5 -56.17 9.03 Favored 'General case' 0 C--N 1.386 2.159 1 C-N-CA 131.939 4.095 . . . . 0.57 112.979 -0.433 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 1.514 ' HB2' ' CB ' ' A' ' 102' ' ' TYR . 87.8 t80 118.89 -154.1 0.0 OUTLIER 'General case' 0 N--CA 1.416 -2.155 1 C-N-CA 132.449 4.3 . . . . 0.57 103.577 5.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.866 ' CG2' ' HA ' ' A' ' 103' ' ' PHE . 59.0 t 121.58 -140.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.251 1.159 0 CA-C-O 128.177 3.846 . . . . 0.57 110.711 -23.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 1.241 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 65.5 t80 85.43 -132.51 0.01 OUTLIER 'General case' 0 CA--C 1.566 1.58 1 N-CA-C 99.856 -4.127 . . . . 0.57 99.856 -163.021 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 105' ' ' PHE . . . -81.38 -70.63 1.33 Allowed Glycine 0 C--N 1.381 3.059 0 C-N-CA 125.13 1.347 . . . . 0.57 113.587 17.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.78 -103.88 0.0 OUTLIER 'Cis proline' 0 N--CA 1.491 1.372 0 N-CA-C 118.107 2.311 . . . . 0.57 118.107 17.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 92.1 m -71.34 106.16 3.77 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 116.628 -2.029 . . . . 0.57 110.739 -135.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.432 ' H ' ' HG3' ' A' ' 183' ' ' MET . . . 60.62 56.99 21.24 Favored Glycine 0 N--CA 1.513 3.776 0 O-C-N 125.648 1.842 . . . . 0.57 113.818 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 1.289 ' CB ' ' SG ' ' A' ' 187' ' ' CYS 2.498 4.8 p 123.29 -65.04 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 117.018 2.229 . . . . 0.57 117.018 172.314 46.484 -114.486 -163.867 89.287 1.262 105.41 89.81 84.215 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.831 ' OD1' ' HE2' ' A' ' 105' ' ' PHE . 0.6 OUTLIER -108.46 45.19 1.04 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 126.956 3.265 . . . . 0.57 105.712 -1.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.8 tt -73.66 -60.7 2.13 Favored 'General case' 0 C--N 1.377 1.801 0 CA-C-N 109.32 -3.582 . . . . 0.57 104.034 165.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -37.78 -83.71 0.01 OUTLIER 'General case' 0 C--O 1.168 -3.185 0 O-C-N 128.837 3.835 . . . . 0.91 112.149 -171.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.81 -15.26 62.03 Favored Glycine 1 CA--C 1.589 4.661 0 CA-C-N 108.573 -3.921 . . . . 0.57 115.216 -170.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -83.44 -100.11 0.05 OUTLIER 'General case' 0 C--O 1.259 1.558 0 N-CA-C 103.51 -2.774 . . . . 0.57 103.51 167.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -46.66 -48.67 19.96 Favored 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 127.312 2.882 . . . . 0.57 114.598 -166.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.91 8.61 0.09 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 115.995 1.85 . . . . 0.57 115.995 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 65.3 p -136.85 -35.7 0.71 Allowed 'General case' 0 C--N 1.383 2.028 0 CA-C-O 126.429 3.014 . . . . 0.57 108.415 171.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.4 tp -64.55 -39.61 94.08 Favored 'General case' 0 N--CA 1.396 -3.132 0 CA-C-N 109.432 -3.531 . . . . 0.57 106.017 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.75 ' HA3' ' H11' ' A' ' 400' ' ' RET . . . -75.29 50.5 2.4 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 126.88 2.181 . . . . 0.57 111.496 162.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 122' ' ' GLU . . . -174.22 -112.92 0.3 Allowed Glycine 0 CA--C 1.532 1.105 2 C-N-CA 132.613 4.911 . . . . 0.57 101.359 165.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -14.02 -83.7 0.0 OUTLIER 'General case' 0 C--O 1.174 -2.889 0 O-C-N 128.401 3.06 . . . . 0.91 111.395 -177.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.4 mt -63.68 -34.4 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 N-CA-C 118.0 2.593 . . . . 0.57 118.0 -170.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . 0.267 . . -55.88 -45.75 78.49 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 115.496 -2.482 . . . . 0.57 114.595 165.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.78 -15.19 49.36 Favored 'General case' 0 C--N 1.385 2.128 0 CA-C-N 110.103 -3.226 . . . . 0.57 111.714 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.44 ' C ' ' H ' ' A' ' 128' ' ' LEU . 1.1 t90 -89.22 -34.99 16.45 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 113.167 -1.833 . . . . 0.57 110.776 174.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . 0.334 7.1 t -54.83 -11.47 0.62 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 116.907 -1.917 . . . . 0.57 112.317 163.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.44 ' H ' ' C ' ' A' ' 126' ' ' TRP 0.29 10.3 tp -67.95 -2.86 8.29 Favored 'General case' 0 N--CA 1.534 3.748 0 N-CA-C 120.89 3.663 . . . . 0.57 120.89 -156.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.6 p -64.51 -29.8 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.816 1 CA-C-N 108.013 -4.176 . . . . 0.57 102.51 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.6 t -81.58 14.96 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.805 0 O-C-N 119.225 -2.172 . . . . 0.57 110.828 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 1.186 ' O ' ' CD2' ' A' ' 136' ' ' TYR . 5.6 tt -119.26 -22.42 7.13 Favored 'General case' 0 N--CA 1.432 -1.327 1 C-N-CA 134.111 4.964 . . . . 0.57 111.982 163.388 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 1.17 ' O ' ' HB3' ' A' ' 136' ' ' TYR . . . -60.24 -37.71 81.21 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-O 125.604 2.621 . . . . 0.57 109.515 171.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.5 pt -86.53 60.29 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.259 1.589 0 CA-C-N 109.707 -3.406 . . . . 0.57 107.621 170.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.831 ' H ' ' CB ' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -178.23 -88.18 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.791 1.237 . . . . 0.91 109.434 167.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 1.354 ' O ' ' CD2' ' A' ' 136' ' ' TYR . 4.2 ttp85 -55.62 77.74 0.0 OUTLIER 'General case' 0 C--N 1.384 2.084 0 CA-C-N 121.372 1.896 . . . . 1.2 110.596 163.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 1.354 ' CD2' ' O ' ' A' ' 135' ' ' ARG 0.362 0.1 OUTLIER 160.01 -111.57 0.0 OUTLIER 'General case' 0 C--O 1.261 1.7 0 N-CA-C 105.108 -2.182 . . . . 0.57 105.108 -128.908 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.886 ' HA ' ' SG ' ' A' ' 140' ' ' CYS . 8.3 p -89.41 54.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.428 3.983 0 N-CA-C 106.21 -1.774 . . . . 0.57 106.21 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.3 p -64.41 -30.97 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.931 0 CA-C-O 124.375 2.036 . . . . 0.57 111.125 155.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.666 ' O ' ' HB2' ' A' ' 140' ' ' CYS . 78.3 t -135.31 -107.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.011 1 N-CA-C 96.777 -5.268 . . . . 0.57 96.777 178.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.886 ' SG ' ' HA ' ' A' ' 137' ' ' VAL 2.475 34.5 m -173.41 -52.18 0.01 OUTLIER 'General case' 0 CA--C 1.597 2.774 0 CA-C-N 121.502 1.955 . . . . 0.57 108.834 -173.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.526 ' CG ' ' HB2' ' A' ' 225' ' ' GLN 0.346 0.0 OUTLIER 47.54 83.78 0.21 Allowed Pre-proline 0 N--CA 1.52 3.032 0 O-C-N 127.081 2.738 . . . . 0.57 105.623 -154.041 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . 0.252 9.0 Cg_endo -63.0 124.4 13.92 Favored 'Trans proline' 0 CA--C 1.587 3.157 0 CA-C-O 116.991 -1.337 . . . . 0.57 113.907 -150.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 5.1 mpp? 62.34 -24.27 0.05 Allowed 'General case' 0 CA--C 1.557 1.23 0 O-C-N 127.824 3.203 . . . . 0.57 113.168 170.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.5 m 81.14 -61.63 0.21 Allowed 'General case' 0 CA--C 1.585 2.301 0 C-N-CA 129.151 2.981 . . . . 0.57 111.942 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.257 40.2 t30 -165.2 -144.55 0.07 Allowed 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 114.652 -2.594 . . . . 0.57 108.371 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -58.13 -36.23 72.64 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 113.409 -3.186 . . . . 0.57 110.745 165.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -137.25 -172.84 3.3 Favored 'General case' 0 C--N 1.373 1.629 1 O-C-N 130.734 5.021 . . . . 1.2 107.645 160.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -93.07 120.27 33.18 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 127.963 3.289 . . . . 0.57 105.171 -38.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.455 ' O ' ' ND2' ' A' ' 151' ' ' ASN . . . -105.87 -19.44 10.25 Favored Glycine 0 N--CA 1.504 3.201 0 O-C-N 127.153 2.783 . . . . 0.57 107.107 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -62.04 70.89 0.01 OUTLIER 'General case' 0 N--CA 1.394 -3.261 0 CA-C-N 112.048 -2.076 . . . . 0.91 113.731 154.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 149' ' ' GLY 0.257 0.9 OUTLIER -42.6 -46.43 4.94 Favored 'General case' 0 N--CA 1.512 2.663 0 C-N-CA 123.926 0.89 . . . . 0.57 112.693 -155.188 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . 0.304 2.0 p-80 -62.32 -140.78 0.0 OUTLIER 'General case' 0 CA--C 1.582 2.203 0 N-CA-C 115.948 1.833 . . . . 0.57 115.948 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.44 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . 62.68 -90.5 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 CA-C-O 124.026 1.87 . . . . 0.57 112.759 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.33 -50.59 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 O-C-N 119.125 -2.234 . . . . 0.57 110.684 -175.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -126.44 63.88 1.26 Allowed 'General case' 0 C--O 1.27 2.167 0 CA-C-N 111.812 -2.449 . . . . 0.57 114.0 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 153' ' ' ALA . . . 81.97 -142.91 22.78 Favored Glycine 2 CA--C 1.617 6.41 0 O-C-N 117.719 -3.113 . . . . 0.57 107.027 -11.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.255 17.6 m -65.79 -36.93 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 114.074 1.139 . . . . 0.57 114.074 -174.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.39 58.66 4.2 Favored 'General case' 0 N--CA 1.401 -2.921 0 O-C-N 127.49 2.994 . . . . 0.57 107.038 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.468 ' CD2' ' HB2' ' A' ' 132' ' ' ALA . 86.4 t80 -163.84 -75.18 0.04 OUTLIER 'General case' 0 CA--C 1.478 -1.824 0 C-N-CA 128.125 2.57 . . . . 0.57 107.635 170.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -44.79 84.44 Favored 'General case' 0 CA--C 1.578 2.023 0 C-N-CA 127.816 2.446 . . . . 0.57 109.54 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.16 29.9 0.22 Allowed 'General case' 0 N--CA 1.527 3.415 0 CA-C-N 113.567 -1.652 . . . . 0.57 112.365 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.9 t -127.93 -60.27 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.6 2.868 0 N-CA-C 101.203 -3.628 . . . . 0.57 101.203 167.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . 0.253 86.8 mtp -64.67 -40.99 96.36 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 122.887 1.327 . . . . 0.57 109.341 -167.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.03 97.42 11.16 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 118.002 -1.479 . . . . 0.57 111.602 144.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.425 ' C ' ' N ' ' A' ' 167' ' ' CYS . 13.5 tp -134.37 -6.54 2.59 Favored 'General case' 0 N--CA 1.404 -2.739 0 O-C-N 129.08 3.988 . . . . 0.57 111.288 154.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.1 15.11 0.03 OUTLIER 'General case' 1 N--CA 1.544 4.274 0 CA-C-O 127.455 3.502 . . . . 0.57 112.997 166.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.485 ' O ' ' CD ' ' A' ' 171' ' ' PRO . 3.5 m -59.01 4.0 0.03 OUTLIER 'General case' 0 C--O 1.257 1.463 0 CA-C-N 109.745 -3.389 . . . . 0.57 111.933 168.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.39 -22.32 57.56 Favored 'General case' 0 CA--C 1.572 1.806 0 CA-C-O 117.284 -1.341 . . . . 0.57 107.71 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.53 ' HB2' ' SD ' ' A' ' 207' ' ' MET . . . -65.88 -51.21 49.13 Favored Pre-proline 0 C--O 1.212 -0.91 0 N-CA-C 116.846 2.165 . . . . 0.57 116.846 173.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . 0.477 14.5 Cg_exo -32.19 -60.96 0.17 Allowed 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.493 2.129 . . . . 0.57 115.725 166.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.485 ' CD ' ' O ' ' A' ' 167' ' ' CYS . 2.8 Cg_exo -51.37 -93.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.187 0 N-CA-C 121.084 3.455 . . . . 0.57 121.084 153.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 13.2 mt -69.13 -40.88 78.01 Favored 'General case' 1 N--CA 1.552 4.655 0 CA-C-O 125.876 2.751 . . . . 0.57 114.532 -157.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 38.2 t -60.75 -40.5 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 117.34 -3.35 . . . . 0.57 106.983 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.7 -33.64 57.71 Favored Glycine 1 CA--C 1.596 5.118 0 CA-C-N 112.4 -2.182 . . . . 0.57 111.979 -166.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -62.18 -34.57 76.68 Favored 'General case' 0 N--CA 1.52 3.054 1 O-C-N 130.01 4.006 . . . . 0.57 104.507 169.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.89 25.74 0.44 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 112.397 -3.721 . . . . 0.57 111.369 175.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -126.78 24.69 6.49 Favored 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 122.526 1.155 . . . . 1.2 107.95 162.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -167.17 67.92 0.09 Allowed 'General case' 0 C--N 1.373 1.596 0 CA-C-N 111.997 -2.365 . . . . 0.57 107.651 -164.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.97 ' CD1' ' CD2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -90.74 175.21 3.82 Favored Pre-proline 0 C--N 1.37 1.48 0 C-N-CA 130.933 3.693 . . . . 0.57 103.914 -5.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.96 118.61 0.3 Allowed 'Cis proline' 0 C--O 1.279 2.548 0 N-CA-C 115.765 1.41 . . . . 0.57 115.765 -15.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.603 ' O ' ' HB3' ' A' ' 185' ' ' CYS . 0.2 OUTLIER -74.55 125.62 29.02 Favored 'General case' 0 C--N 1.382 1.99 0 C-N-CA 116.601 -2.04 . . . . 0.91 106.413 -163.007 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 1.099 ' HA2' ' CB ' ' A' ' 187' ' ' CYS . . . -85.32 41.21 3.05 Favored Glycine 1 CA--C 1.612 6.133 1 C-N-CA 113.519 -4.181 . . . . 0.57 116.851 -169.748 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.432 ' HG3' ' H ' ' A' ' 109' ' ' GLY . 73.3 mtm -152.69 -50.52 0.1 Allowed 'General case' 0 CA--C 1.595 2.695 0 C-N-CA 128.23 2.612 . . . . 0.57 111.627 168.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -66.19 -33.17 75.16 Favored 'General case' 0 C--N 1.394 2.539 1 C-N-CA 108.807 -5.157 . . . . 0.57 111.764 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.888 ' SG ' ' O ' ' A' ' 189' ' ' ILE . 52.2 t -72.91 -22.8 60.68 Favored 'General case' 0 CA--C 1.482 -1.671 0 O-C-N 127.155 2.784 . . . . 0.57 112.057 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.918 ' O ' ' SG ' ' A' ' 187' ' ' CYS 0.262 0.7 OUTLIER 86.61 -53.37 0.06 Allowed 'General case' 0 CA--C 1.606 3.125 0 C-N-CA 129.556 3.142 . . . . 0.57 110.715 -159.975 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 1.289 ' SG ' ' CB ' ' A' ' 110' ' ' CYS 2.476 2.1 p -158.43 42.06 0.26 Allowed 'General case' 0 C--O 1.251 1.17 0 CA-C-O 125.173 2.416 . . . . 0.57 111.141 168.101 84.215 89.81 -163.867 105.41 1.262 89.287 -114.486 46.484 3 3 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.494 ' H ' ' HB3' ' A' ' 185' ' ' CYS . . . 62.69 170.44 1.19 Allowed Glycine 0 N--CA 1.515 3.933 1 C-N-CA 112.073 -4.87 . . . . 0.57 109.901 -144.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.888 ' O ' ' SG ' ' A' ' 185' ' ' CYS 0.275 5.2 pt -74.48 158.03 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.435 0 CA-C-N 122.345 3.073 . . . . 0.57 108.269 21.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.661 ' O ' ' HB3' ' A' ' 191' ' ' TYR . 16.7 t70 -153.04 -134.83 0.05 Allowed 'General case' 0 CA--C 1.561 1.39 1 C-N-CA 133.412 4.685 . . . . 0.91 105.614 6.108 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.074 ' CD2' ' O ' ' A' ' 191' ' ' TYR . 54.8 t80 82.65 38.59 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.307 -1.77 . . . . 0.57 113.862 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -98.18 -132.59 0.23 Allowed 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 110.689 -2.96 . . . . 0.57 107.018 157.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.557 80.4 p 73.39 -122.14 0.0 OUTLIER Pre-proline 0 CA--C 1.577 2.003 0 O-C-N 128.298 3.499 . . . . 0.57 101.732 -162.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -40.99 115.35 0.35 Allowed 'Trans proline' 0 N--CA 1.421 -2.757 0 N-CA-C 118.931 2.627 . . . . 0.57 118.931 171.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 1.342 ' HB3' ' OG1' ' A' ' 198' ' ' THR . 49.1 m-70 -136.98 75.89 1.56 Allowed 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 125.72 1.888 . . . . 0.57 108.18 -7.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -55.64 -22.71 24.09 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-O 125.814 2.721 . . . . 0.91 116.463 170.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.73 -68.16 0.6 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 111.66 -2.518 . . . . 0.91 107.417 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 1.342 ' OG1' ' HB3' ' A' ' 195' ' ' HIS . 82.5 p -68.06 -18.43 64.68 Favored 'General case' 0 CA--C 1.614 3.44 1 O-C-N 129.95 4.531 . . . . 0.57 116.742 -169.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -119.52 56.23 0.94 Allowed 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 123.315 1.531 . . . . 0.57 110.361 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -73.97 -13.95 60.96 Favored 'General case' 0 CA--C 1.587 2.383 0 CA-C-N 111.466 -2.606 . . . . 0.57 109.868 166.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -53.98 -111.12 0.0 OUTLIER 'General case' 0 CA--C 1.628 3.954 0 N-CA-C 105.638 -1.986 . . . . 0.91 105.638 157.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 58.8 m -75.63 90.88 2.82 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-O 122.035 0.921 . . . . 0.57 113.229 -168.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -176.19 -128.76 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 109.903 -3.317 . . . . 0.57 103.937 168.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.22 150.79 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.444 0 O-C-N 127.131 2.769 . . . . 0.57 107.736 137.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 13.3 pt -92.97 3.78 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 N-CA-C 103.665 -2.717 . . . . 0.57 103.665 -2.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.71 -33.54 34.9 Favored 'General case' 0 C--N 1.376 1.759 0 N-CA-C 118.0 2.593 . . . . 0.57 118.0 -159.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 1.571 ' HG3' ' C3 ' ' A' ' 400' ' ' RET . 28.8 mmt -59.51 -27.75 66.45 Favored 'General case' 0 N--CA 1.421 -1.925 0 O-C-N 124.159 0.912 . . . . 0.57 111.154 -174.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -92.44 -47.14 7.31 Favored 'General case' 0 C--N 1.39 2.334 0 C-N-CA 117.583 -1.647 . . . . 0.57 110.552 155.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.527 ' CG1' ' H ' ' A' ' 210' ' ' VAL 0.337 3.4 p 38.4 -103.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 124.786 2.231 . . . . 0.57 111.786 -162.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.527 ' H ' ' CG1' ' A' ' 209' ' ' VAL . 11.3 m -129.93 3.7 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 127.855 2.462 . . . . 0.57 110.785 155.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.435 ' C ' ' H ' ' A' ' 213' ' ' ILE . 8.7 t60 -44.57 -65.25 0.54 Allowed 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 112.337 -2.21 . . . . 0.57 112.796 174.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -81.94 47.3 1.09 Allowed 'General case' 0 CA--C 1.604 3.047 0 CA-C-O 125.043 2.354 . . . . 0.57 111.845 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.435 ' H ' ' C ' ' A' ' 211' ' ' HIS . 22.1 mm -96.0 -5.02 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 124.946 2.307 . . . . 0.57 106.77 162.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . 0.302 1.3 pt -31.15 -57.72 0.36 Allowed Pre-proline 0 N--CA 1.492 1.637 0 CA-C-O 115.234 -2.317 . . . . 0.57 114.109 167.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -75.65 -4.16 14.86 Favored 'Trans proline' 0 C--N 1.384 2.4 0 CA-C-N 125.338 2.942 . . . . 0.57 115.102 -171.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.42 -64.46 1.18 Allowed 'General case' 0 CA--C 1.585 2.326 0 O-C-N 120.136 -1.602 . . . . 0.57 106.73 165.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . 0.361 5.1 tt -65.93 -46.93 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.604 3.046 0 CA-C-N 112.656 -2.066 . . . . 0.57 110.914 -153.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.13 -41.9 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 122.031 2.196 . . . . 0.57 107.6 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.9 mm -75.34 149.09 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.441 -3.227 0 CA-C-O 112.286 -3.721 . . . . 0.57 102.588 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . 0.51 ' CE2' ' HG2' ' A' ' 135' ' ' ARG . 1.7 t80 -87.48 -26.42 23.23 Favored 'General case' 0 C--O 1.199 -1.564 1 C-N-CA 134.718 5.207 . . . . 0.57 107.926 1.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.403 ' C ' ' H ' ' A' ' 223' ' ' TYR 0.277 28.5 p90 -52.26 -38.21 57.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 126.575 2.422 . . . . 0.57 112.289 -165.07 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . 0.335 30.2 p -63.75 13.97 0.02 OUTLIER 'General case' 0 N--CA 1.392 -3.355 1 O-C-N 129.151 4.032 . . . . 0.57 118.357 -159.621 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.403 ' H ' ' C ' ' A' ' 221' ' ' PHE 0.303 0.1 OUTLIER -89.47 -9.15 51.16 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 129.242 3.017 . . . . 0.57 107.167 -172.497 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.65 -56.1 5.01 Favored Glycine 0 N--CA 1.396 -3.989 0 N-CA-C 107.824 -2.11 . . . . 0.57 107.824 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.526 ' HB2' ' CG ' ' A' ' 141' ' ' LYS . 37.8 tp60 -75.73 -23.27 56.03 Favored 'General case' 0 C--N 1.377 1.799 0 O-C-N 120.96 -1.317 . . . . 0.57 109.154 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.73 9.33 21.96 Favored 'General case' 0 C--O 1.202 -1.4 0 O-C-N 128.048 3.343 . . . . 0.57 108.718 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 15.1 t -106.26 41.87 0.21 Allowed 'Isoleucine or valine' 1 CA--C 1.632 4.105 1 N-CA-C 99.887 -4.116 . . . . 0.57 99.887 163.361 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -170.02 39.09 0.02 OUTLIER 'General case' 0 C--N 1.41 3.234 0 C-N-CA 125.552 1.541 . . . . 0.57 109.481 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 6.6 m -165.47 152.72 10.55 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 104.766 -2.309 . . . . 0.57 104.766 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . 0.251 34.3 m 46.33 -64.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 128.648 3.717 . . . . 0.57 116.605 -169.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.513 ' HZ1' ' CD ' ' A' ' 232' ' ' GLU . 15.8 ttpp -57.07 -32.62 66.43 Favored 'General case' 0 CA--C 1.584 2.287 0 O-C-N 126.008 2.067 . . . . 0.57 113.675 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.513 ' CD ' ' HZ1' ' A' ' 231' ' ' LYS . 2.9 mp0 -88.13 111.64 21.81 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.641 -1.614 . . . . 0.91 106.641 165.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -60.63 -9.31 3.69 Favored 'General case' 0 C--O 1.202 -1.396 0 C-N-CA 113.809 -3.156 . . . . 0.57 113.227 166.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.05 31.93 0.01 OUTLIER 'General case' 0 C--N 1.36 1.045 0 N-CA-C 116.495 2.035 . . . . 0.57 116.495 158.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -169.02 163.61 11.32 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 107.953 -1.128 . . . . 0.57 107.953 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 71.76 -51.53 0.69 Allowed 'General case' 0 N--CA 1.485 1.309 1 C-N-CA 134.281 5.032 . . . . 0.57 109.974 175.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -42.11 -92.55 0.0 OUTLIER 'General case' 0 N--CA 1.402 -2.861 0 O-C-N 128.22 3.45 . . . . 0.57 111.813 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -36.75 65.03 Favored 'General case' 0 C--N 1.377 1.793 0 CA-C-N 113.11 -1.859 . . . . 0.57 109.408 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.617 ' O ' ' HB3' ' A' ' 240' ' ' SER 0.292 0.3 OUTLIER -110.28 78.24 1.11 Allowed 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 125.081 2.372 . . . . 0.91 105.629 -169.456 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 1.036 ' OG ' ' HA ' ' A' ' 251' ' ' THR . 88.6 p 160.98 -23.05 0.0 OUTLIER 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 109.451 -3.522 . . . . 0.57 107.005 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 1.042 ' O ' ' CG2' ' A' ' 242' ' ' THR 0.321 . . -61.81 -32.48 72.79 Favored 'General case' 0 N--CA 1.514 2.743 0 CA-C-O 123.039 1.399 . . . . 0.57 113.541 158.409 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 1.042 ' CG2' ' O ' ' A' ' 241' ' ' ALA 0.363 9.1 t 170.37 42.56 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.536 0 C-N-CA 116.192 -2.203 . . . . 0.57 106.672 -178.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . 0.254 15.4 m -149.52 134.09 17.62 Favored 'General case' 0 CA--C 1.587 2.396 1 CA-C-O 128.874 4.178 . . . . 0.57 109.959 168.465 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? 85.78 -45.95 0.06 Allowed 'General case' 1 C--N 1.435 4.299 1 CA-C-N 105.037 -5.529 . . . . 0.57 109.604 166.97 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.44 ' HG3' ' HB ' ' A' ' 250' ' ' VAL . 10.0 pttm -132.13 -174.66 3.5 Favored 'General case' 0 C--O 1.271 2.185 0 CA-C-N 112.703 -2.044 . . . . 0.57 111.677 -171.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 309' ' ' MET . . . -56.27 145.53 26.45 Favored 'General case' 0 CA--C 1.591 2.52 0 CA-C-N 109.84 -3.345 . . . . 0.57 107.985 170.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 1.28 ' O ' ' CG2' ' A' ' 250' ' ' VAL 0.445 0.0 OUTLIER -81.41 -123.34 0.02 OUTLIER 'General case' 0 C--O 1.204 -1.334 0 O-C-N 127.057 2.723 . . . . 0.91 109.396 -148.72 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.532 ' H ' ' HG2' ' A' ' 247' ' ' GLU . 3.6 ttpm? -36.14 -30.19 0.02 OUTLIER 'General case' 0 C--N 1.345 0.39 0 C-N-CA 128.885 2.874 . . . . 0.57 118.213 -173.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.16 -39.23 19.67 Favored 'General case' 0 CA--C 1.571 1.783 0 C-N-CA 115.025 -2.67 . . . . 0.91 107.706 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 1.28 ' CG2' ' O ' ' A' ' 247' ' ' GLU . 33.7 m -64.92 -17.26 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.357 0 CA-C-N 112.33 -2.214 . . . . 0.57 109.169 169.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 1.036 ' HA ' ' OG ' ' A' ' 240' ' ' SER . 1.1 m -68.03 -44.85 75.51 Favored 'General case' 0 C--N 1.401 2.827 1 C-N-CA 109.864 -4.734 . . . . 0.57 112.518 160.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -59.03 -22.65 61.03 Favored 'General case' 0 N--CA 1.395 -3.176 0 N-CA-C 116.121 1.897 . . . . 1.2 116.121 -167.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' MET . . . . . . . . . . . . . 9.2 ttt -82.36 27.21 0.51 Allowed 'General case' 0 C--N 1.395 2.56 0 CA-C-O 124.988 2.328 . . . . 0.57 111.979 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.11 -16.99 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.241 0 CA-C-N 112.552 -2.113 . . . . 0.57 111.819 145.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 3.6 tp -148.0 -35.12 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-O 123.895 1.807 . . . . 0.57 115.835 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 40.5 mm -51.73 -29.58 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.054 0 N-CA-C 115.785 1.772 . . . . 0.57 115.785 162.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' MET . . . . . 1.116 ' HE1' ' HG2' ' A' ' 135' ' ' ARG . 1.7 tpt -41.41 -55.05 2.91 Favored 'General case' 0 C--N 1.393 2.458 0 O-C-N 128.122 3.389 . . . . 0.57 109.025 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.4 t -75.98 -19.51 15.44 Favored 'Isoleucine or valine' 0 C--N 1.363 1.182 0 O-C-N 125.917 2.01 . . . . 0.57 107.246 -160.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . 0.292 86.3 mt -84.99 14.53 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 126.598 1.959 . . . . 0.57 112.454 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -95.7 -32.11 12.91 Favored 'General case' 0 C--O 1.262 1.75 0 C-N-CA 124.893 1.277 . . . . 0.57 107.894 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.503 ' HD2' ' NE ' ' A' ' 135' ' ' ARG . 6.5 p90 -124.71 8.11 8.2 Favored 'General case' 0 C--O 1.258 1.504 0 CA-C-O 117.486 -1.245 . . . . 0.57 111.649 -174.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . 0.352 0.4 OUTLIER -128.61 25.17 5.72 Favored 'General case' 1 N--CA 1.55 4.554 0 CA-C-N 122.803 2.547 . . . . 0.57 111.607 168.542 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . 0.3 16.5 tt -96.73 142.74 13.52 Favored 'Isoleucine or valine' 0 C--O 1.269 2.1 0 N-CA-C 100.927 -3.731 . . . . 0.57 100.927 176.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' CYS . . . . . . . . . . . . . 99.7 m 51.8 -73.65 0.01 OUTLIER 'General case' 0 C--N 1.281 -2.409 1 C-N-CA 133.126 4.571 . . . . 0.57 110.252 -177.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' TRP . . . . . 0.907 ' CE3' H193 ' A' ' 400' ' ' RET 0.486 44.0 t-105 -58.16 -53.58 56.63 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 118.378 -2.701 . . . . 0.57 114.115 -167.567 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.1 tt -44.56 -68.28 0.3 Allowed Pre-proline 0 C--O 1.274 2.375 0 O-C-N 120.807 -1.183 . . . . 0.57 110.626 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.11 4.21 3.43 Favored 'Trans proline' 0 N--CA 1.519 3.008 0 C-N-CA 123.067 2.511 . . . . 0.57 115.487 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.59 -23.58 53.49 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 115.565 -2.454 . . . . 0.57 117.346 -166.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . 0.372 . . -53.02 -35.13 59.08 Favored 'General case' 0 N--CA 1.534 3.742 0 N-CA-C 116.815 2.154 . . . . 0.57 116.815 174.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -72.83 -17.31 78.28 Favored Glycine 1 CA--C 1.603 5.537 0 C-N-CA 117.644 -2.217 . . . . 0.57 111.459 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 24.0 t -82.82 -43.24 18.6 Favored 'Isoleucine or valine' 0 C--O 1.267 2.025 0 CA-C-N 112.995 -1.603 . . . . 0.57 109.228 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -68.51 -41.34 80.1 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-O 125.619 2.628 . . . . 0.57 115.981 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -44.51 -56.98 3.87 Favored 'General case' 0 C--O 1.277 2.547 0 CA-C-N 111.925 -2.398 . . . . 0.57 110.322 169.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -129.14 93.43 3.58 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 116.234 -2.186 . . . . 0.57 106.926 170.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 16.5 tt -157.7 150.96 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.578 0 CA-C-O 123.44 1.591 . . . . 0.57 108.088 7.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -168.01 51.36 0.05 Allowed 'General case' 0 CA--C 1.592 2.559 0 C-N-CA 128.677 2.791 . . . . 0.57 109.422 162.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . 0.289 15.1 p -162.82 138.8 7.18 Favored 'General case' 0 CA--C 1.58 2.107 0 N-CA-C 101.272 -3.603 . . . . 0.57 101.272 -177.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 42.28 -178.63 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.491 0 O-C-N 127.659 3.1 . . . . 0.57 117.655 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . 0.308 0.5 OUTLIER 131.96 -57.65 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 112.079 -2.328 . . . . 0.57 106.312 165.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 176.03 106.7 0.2 Allowed Glycine 0 N--CA 1.415 -2.709 2 O-C-N 130.015 4.572 . . . . 0.57 102.965 171.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . 0.308 1.9 m -54.4 145.3 18.5 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 112.225 -1.988 . . . . 0.57 108.08 -174.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASP . . . . . . . . . . . . . 11.4 t70 94.87 -78.02 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 105.806 -1.924 . . . . 0.91 105.806 -171.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -88.01 87.13 7.24 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 114.381 -2.928 . . . . 0.57 106.779 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 81.99 89.35 0.64 Allowed Glycine 0 CA--C 1.46 -3.371 0 CA-C-N 110.076 -3.238 . . . . 0.57 108.919 157.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.96 122.94 9.05 Favored 'Cis proline' 1 C--N 1.417 4.148 0 O-C-N 123.29 1.152 . . . . 0.57 111.306 7.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . 0.272 1.1 pp -112.16 99.04 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.193 1.397 . . . . 0.57 112.081 49.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -94.13 68.14 3.68 Favored 'General case' 0 CA--C 1.585 2.326 0 CA-C-O 123.475 1.607 . . . . 0.57 108.604 -172.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' MET . . . . . 0.452 ' SD ' ' HG ' ' A' ' 99' ' ' LEU . 31.7 mmt -72.7 -32.76 66.0 Favored 'General case' 0 N--CA 1.51 2.531 0 CA-C-N 110.948 -2.842 . . . . 0.57 114.122 -174.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 288' ' ' MET . 1.7 t -23.18 -103.26 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.787 0 CA-C-N 110.804 -2.907 . . . . 0.57 111.293 165.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . 0.286 3.0 mt -69.77 -64.7 1.39 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 119.008 -2.307 . . . . 0.57 113.337 -173.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -50.61 -19.34 4.9 Favored 'Trans proline' 0 N--CA 1.516 2.81 0 C-N-CA 125.049 3.832 . . . . 0.57 117.532 -167.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -103.26 -8.15 20.58 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 120.589 1.541 . . . . 0.57 112.457 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -75.27 -28.74 59.91 Favored 'General case' 0 N--CA 1.518 2.966 0 C-N-CA 113.992 -3.083 . . . . 0.57 114.81 -162.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -74.08 -45.15 51.13 Favored 'General case' 0 C--N 1.379 1.876 0 O-C-N 126.856 2.597 . . . . 0.57 108.998 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . 0.49 ' HB1' ' C12' ' A' ' 400' ' ' RET . . . -71.21 -29.26 64.93 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 102.935 -2.987 . . . . 0.57 102.935 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . 1.227 ' HG2' ' OH ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -96.42 19.03 12.73 Favored 'General case' 0 C--N 1.353 0.742 1 C-N-CA 108.735 -5.186 . . . . 0.0 109.331 -174.764 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 2.4 m -72.79 -10.13 59.44 Favored 'General case' 0 CA--C 1.575 1.926 0 O-C-N 117.903 -2.998 . . . . 0.57 114.386 157.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' SER . . . . . 0.431 ' HB2' ' SD ' ' A' ' 86' ' ' MET . 46.9 m -44.06 -28.09 0.45 Allowed 'General case' 0 N--CA 1.518 2.974 0 O-C-N 128.939 3.899 . . . . 0.57 112.383 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -57.01 -10.77 1.21 Allowed 'General case' 0 N--CA 1.41 -2.46 0 O-C-N 118.513 -2.617 . . . . 0.57 117.952 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 5.4 t -82.38 76.26 1.04 Allowed 'Isoleucine or valine' 1 N--CA 1.376 -4.159 0 CA-C-O 124.34 2.019 . . . . 0.57 108.706 166.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -73.12 79.65 1.25 Allowed 'General case' 0 C--N 1.404 2.954 0 CA-C-N 113.832 -1.531 . . . . 0.57 107.111 161.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -145.53 -63.96 0.02 OUTLIER Pre-proline 0 CA--C 1.578 2.036 0 C-N-CA 125.862 1.665 . . . . 0.57 109.084 173.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -81.28 -22.01 6.11 Favored 'Trans proline' 0 N--CA 1.422 -2.717 0 C-N-CA 116.755 -1.697 . . . . 0.57 110.202 174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 53.6 t -51.92 -67.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 114.223 -1.353 . . . . 0.57 109.531 165.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . 0.271 35.3 pt -63.24 -23.68 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.481 1 O-C-N 129.163 4.039 . . . . 0.57 109.251 -172.31 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -54.39 -36.62 64.12 Favored 'General case' 0 C--O 1.255 1.363 0 O-C-N 120.332 -1.48 . . . . 0.57 110.503 -157.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 3.7 mm -95.65 61.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 124.678 1.236 . . . . 0.57 109.791 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' MET . . . . . 1.099 ' O ' ' HG2' ' A' ' 309' ' ' MET . 5.6 mtm -65.72 -91.63 0.01 OUTLIER 'General case' 0 CA--C 1.583 2.218 0 CA-C-N 111.505 -2.589 . . . . 0.57 110.836 171.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' MET . . . . . 1.243 ' SD ' ' N ' ' A' ' 310' ' ' ASN 0.423 0.0 OUTLIER 125.68 -111.43 0.0 OUTLIER 'General case' 0 CA--C 1.464 -2.343 0 C-N-CA 125.804 1.641 . . . . 0.57 112.435 -178.566 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ASN . . . . . 1.243 ' N ' ' SD ' ' A' ' 309' ' ' MET . 24.9 t-20 -71.04 -20.41 62.38 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 116.606 2.076 . . . . 0.57 116.606 -160.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.617 ' N ' ' SD ' ' A' ' 309' ' ' MET . 20.2 mmtm -117.58 28.51 8.4 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 108.937 -3.756 . . . . 0.57 109.528 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' GLN . . . . . 0.419 ' O ' ' CB ' ' A' ' 313' ' ' PHE 0.28 30.0 tt0 -125.14 97.36 5.2 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 103.825 -2.657 . . . . 0.57 103.825 148.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 1.039 ' HE2' ' CG2' ' A' ' 342' ' ' THR 0.325 35.7 t80 90.17 118.11 0.03 OUTLIER 'General case' 0 CA--C 1.597 2.779 0 CA-C-N 113.093 -1.867 . . . . 0.57 106.363 -170.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.38 47.48 3.07 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 112.567 -2.106 . . . . 1.2 109.231 -149.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 316' ' ' CYS . 26.0 t30 -93.63 -44.46 8.18 Favored 'General case' 0 C--N 1.368 1.39 0 O-C-N 126.005 2.066 . . . . 0.57 112.7 -171.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' CYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 315' ' ' ASN . 4.9 m 71.93 -131.57 0.04 OUTLIER 'General case' 0 CA--C 1.586 2.35 0 N-CA-C 101.073 -3.677 . . . . 0.57 101.073 -165.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' MET . . . . . 0.73 ' O ' ' CG2' ' A' ' 318' ' ' VAL 0.444 2.1 tpp -55.2 117.23 3.32 Favored 'General case' 0 N--CA 1.409 -2.523 0 C-N-CA 125.799 1.64 . . . . 0.57 112.893 -159.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.839 ' CG1' ' O ' ' A' ' 61' ' ' VAL . 9.5 t 100.97 42.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.926 -1.509 . . . . 0.57 106.926 171.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 3.7 m -66.89 39.52 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 131.342 3.857 . . . . 0.57 114.968 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 5.1 m -137.02 64.55 1.53 Allowed 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 109.261 -3.609 . . . . 0.57 110.842 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 8.7 mt -135.7 172.34 13.16 Favored 'General case' 0 N--CA 1.523 3.221 0 CA-C-N 110.66 -2.973 . . . . 0.57 109.811 -175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 97.3 m -69.73 142.22 53.33 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 113.25 -1.795 . . . . 0.57 112.692 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.524 ' SG ' ' HA ' ' A' ' 326' ' ' ASN . 23.4 p -173.44 -110.41 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.432 0 C-N-CA 112.018 -3.873 . . . . 0.57 110.167 -163.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -134.46 -70.81 0.07 OUTLIER Glycine 1 N--CA 1.606 9.992 0 C-N-CA 128.626 3.012 . . . . 0.57 107.318 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -60.72 -49.89 75.68 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 107.108 -1.441 . . . . 0.57 107.108 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.524 ' HA ' ' SG ' ' A' ' 323' ' ' CYS . 1.5 t30 66.87 126.58 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 126.621 2.451 . . . . 0.57 117.57 155.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -82.88 24.05 10.03 Favored 'Cis proline' 0 C--N 1.386 2.534 0 CA-C-O 127.181 2.909 . . . . 0.57 117.184 -6.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 2.4 tt -143.95 124.57 14.07 Favored 'General case' 0 C--O 1.275 2.399 0 CA-C-N 113.075 -1.875 . . . . 0.57 112.289 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 66.32 -149.88 51.63 Favored Glycine 1 CA--C 1.606 5.763 0 O-C-N 127.583 3.052 . . . . 0.57 108.801 162.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.769 ' HB3' ' HB3' ' A' ' 343' ' ' SER . 10.9 m-20 -64.43 113.32 3.57 Favored 'General case' 0 C--O 1.176 -2.796 0 CA-C-O 126.693 3.14 . . . . 0.91 111.618 -32.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -146.0 82.39 1.61 Allowed 'General case' 0 N--CA 1.413 -2.307 1 CA-C-N 107.195 -4.548 . . . . 0.91 108.959 -173.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.842 ' O ' ' CB ' ' A' ' 333' ' ' ALA 0.312 0.8 OUTLIER -58.24 -46.34 86.11 Favored 'General case' 0 C--O 1.205 -1.257 0 CA-C-N 112.641 -2.072 . . . . 0.91 114.72 162.411 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . 0.842 ' CB ' ' O ' ' A' ' 332' ' ' GLU . . . 132.99 -117.04 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 117.724 -1.59 . . . . 0.57 109.863 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' SER . . . . . 1.326 ' O ' ' CG2' ' A' ' 335' ' ' THR 0.511 90.9 p 58.87 -122.0 1.21 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 110.755 -2.929 . . . . 0.57 111.27 -157.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 1.326 ' CG2' ' O ' ' A' ' 334' ' ' SER . 40.7 p 143.16 68.81 0.0 OUTLIER 'General case' 0 N--CA 1.403 -2.822 0 O-C-N 127.982 3.301 . . . . 0.57 108.564 -158.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.848 ' O ' ' HB ' ' A' ' 337' ' ' VAL 0.261 0.2 OUTLIER -135.67 55.9 1.85 Allowed 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 101.967 -3.345 . . . . 0.57 101.967 -168.715 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.848 ' HB ' ' O ' ' A' ' 336' ' ' THR 0.367 21.9 t 80.04 -129.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 CA-C-N 111.562 -2.563 . . . . 0.57 109.953 177.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' SER . . . . . 0.834 ' H ' ' CG1' ' A' ' 337' ' ' VAL 0.298 5.0 m -78.08 -166.3 0.79 Allowed 'General case' 0 C--N 1.38 1.924 0 N-CA-C 117.025 2.231 . . . . 0.57 117.025 -172.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . 0.508 ' HZ1' ' CD ' ' A' ' 341' ' ' GLU . 2.0 ttpm? -124.82 145.1 49.94 Favored 'General case' 0 C--N 1.416 3.489 0 N-CA-C 107.199 -1.408 . . . . 0.57 107.199 172.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' THR . . . . . 0.969 ' O ' ' CZ ' ' A' ' 313' ' ' PHE . 0.2 OUTLIER -84.27 -172.44 4.17 Favored 'General case' 0 C--O 1.256 1.416 0 C-N-CA 117.293 -1.763 . . . . 0.57 106.963 167.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.508 ' CD ' ' HZ1' ' A' ' 339' ' ' LYS . 26.8 mm-40 -109.89 74.6 0.9 Allowed 'General case' 0 C--O 1.264 1.867 0 O-C-N 117.236 -3.415 . . . . 0.91 106.932 160.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 1.039 ' CG2' ' HE2' ' A' ' 313' ' ' PHE . 1.3 m -144.0 -101.5 0.11 Allowed 'General case' 0 C--N 1.403 2.893 0 CA-C-O 113.471 -3.157 . . . . 0.57 107.436 34.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' SER . . . . . 0.769 ' HB3' ' HB3' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -79.78 55.56 2.08 Favored 'General case' 0 N--CA 1.397 -3.121 0 O-C-N 128.695 3.747 . . . . 0.57 110.614 -164.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . 0.454 ' C ' HG21 ' A' ' 345' ' ' VAL . 10.0 mt-30 -124.59 -165.97 1.45 Allowed 'General case' 0 N--CA 1.406 -2.627 0 CA-C-N 108.802 -3.817 . . . . 0.57 100.965 172.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.873 ' O ' ' CG2' ' A' ' 345' ' ' VAL 0.378 17.7 m 27.72 69.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.249 1.032 0 O-C-N 127.899 3.25 . . . . 0.57 113.438 164.322 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.402 ' HA ' ' N ' ' A' ' 345' ' ' VAL . . . -137.31 131.62 17.61 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 119.25 -2.156 . . . . 0.57 105.367 -12.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.48 135.83 59.64 Favored 'Trans proline' 0 C--N 1.376 1.976 0 N-CA-C 103.487 -3.313 . . . . 0.57 103.487 140.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.805 0 O-C-N 124.589 1.181 . . . . 0.3 . 24.308 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' RET . . . . . 1.571 ' C3 ' ' HG3' ' A' ' 207' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.525 3.306 0 CA-C-O 116.527 -1.701 . . . . 0.57 111.279 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . 0.286 . . -57.24 -82.45 0.01 OUTLIER 'General case' 0 C--O 1.262 1.734 1 O-C-N 131.749 5.656 . . . . 0.57 108.15 176.016 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' A' ' 45' ' ' PHE . . . -33.41 -49.35 0.28 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 119.166 3.024 . . . . 0.57 119.166 169.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.251 ' OH ' ' HG2' ' A' ' 296' ' ' LYS . 1.0 OUTLIER -48.81 -61.8 1.85 Allowed 'General case' 0 N--CA 1.425 -1.68 0 C-N-CA 125.51 1.524 . . . . 0.57 107.826 176.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.4 ' C ' ' SD ' ' A' ' 44' ' ' MET . 7.8 tmm? -65.49 -55.9 15.34 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 123.237 1.494 . . . . 0.57 111.302 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.403 ' HB2' ' HA ' ' A' ' 42' ' ' ALA . 5.5 m-30 -37.63 -37.7 0.23 Allowed 'General case' 0 CA--C 1.476 -1.873 0 C-N-CA 129.299 3.04 . . . . 0.57 116.791 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.1 mt -121.31 -66.67 1.03 Allowed 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 125.241 1.416 . . . . 0.57 111.667 174.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 mp -62.05 -42.53 99.28 Favored 'General case' 0 CA--C 1.602 2.967 0 CA-C-N 113.803 -1.544 . . . . 0.57 109.021 -158.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.404 ' O ' ' HZ ' ' A' ' 56' ' ' PHE . 21.5 mm -101.95 15.15 5.43 Favored 'Isoleucine or valine' 0 C--N 1.381 1.941 0 C-N-CA 118.299 -1.36 . . . . 0.57 114.335 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.1 mmm -81.26 70.57 8.13 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 125.81 2.719 . . . . 0.57 106.328 154.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 tp -174.86 -45.88 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.381 1 CA-C-N 105.72 -5.218 . . . . 0.57 104.39 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.588 ' O ' ' CG ' ' A' ' 56' ' ' PHE . . . -54.04 -61.15 7.44 Favored Glycine 0 N--CA 1.501 3.029 0 O-C-N 118.357 -2.714 . . . . 0.57 111.493 161.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 1.005 ' CD1' ' CD1' ' A' ' 56' ' ' PHE . 42.5 m-85 -72.42 136.93 80.99 Favored Pre-proline 0 C--O 1.198 -1.617 0 N-CA-C 105.431 -2.062 . . . . 0.57 105.431 158.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 56' ' ' PHE 0.443 93.0 Cg_endo -94.05 -3.62 42.04 Favored 'Cis proline' 0 C--N 1.387 2.585 0 N-CA-C 117.5 2.077 . . . . 0.57 117.5 -20.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.3 mt -46.95 -65.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.422 3.733 0 CA-C-N 120.46 1.482 . . . . 0.57 113.642 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 59' ' ' LEU . 0.7 OUTLIER -55.91 -51.18 68.53 Favored 'General case' 0 C--N 1.392 2.413 0 CA-C-N 112.342 -2.208 . . . . 0.57 110.656 166.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 1.005 ' CD1' ' CD1' ' A' ' 52' ' ' PHE 0.34 6.0 m-85 -40.71 -66.41 0.33 Allowed 'General case' 0 CA--C 1.592 2.562 0 CA-C-N 114.897 -1.047 . . . . 0.57 111.046 -172.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.9 tp -62.01 -53.76 51.04 Favored 'General case' 0 C--O 1.255 1.381 0 O-C-N 119.521 -1.987 . . . . 0.57 110.175 176.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.323 0.8 OUTLIER -71.56 -3.06 19.25 Favored 'General case' 0 N--CA 1.405 -2.688 0 O-C-N 125.709 1.881 . . . . 0.57 115.373 -169.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 55' ' ' ASN . 3.5 tp -63.85 -41.21 97.85 Favored 'General case' 0 CA--C 1.586 2.34 0 N-CA-C 100.61 -3.848 . . . . 0.57 100.61 173.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -68.99 -43.32 75.1 Favored 'General case' 0 CA--C 1.588 2.409 0 O-C-N 126.897 2.623 . . . . 0.57 106.316 -165.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.244 ' O ' HG11 ' A' ' 318' ' ' VAL . 74.0 t -52.71 -37.21 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.656 0 O-C-N 127.983 3.302 . . . . 0.57 110.878 176.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.7 p -95.18 -81.37 0.4 Allowed 'General case' 0 CA--C 1.577 1.998 0 C-N-CA 115.499 -2.481 . . . . 0.57 113.365 -171.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.511 HG12 HD21 ' A' ' 76' ' ' LEU 0.389 2.6 m -45.71 -65.84 0.16 Allowed 'Isoleucine or valine' 1 N--CA 1.541 4.084 0 CA-C-N 112.465 -2.152 . . . . 0.57 115.408 -151.239 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 36.5 87.08 0.01 OUTLIER 'General case' 0 C--N 1.386 2.163 0 O-C-N 126.077 2.111 . . . . 0.57 115.648 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 40.07 42.28 1.1 Allowed 'General case' 0 C--O 1.211 -0.922 0 CA-C-O 123.516 1.627 . . . . 0.57 110.66 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.518 ' NZ ' ' O ' ' A' ' 77' ' ' LEU . 62.7 mttm 49.31 82.84 0.04 OUTLIER 'General case' 0 N--CA 1.387 -3.592 0 CA-C-N 112.555 -2.111 . . . . 0.57 110.224 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.473 ' NZ ' HG21 ' A' ' 318' ' ' VAL . 24.8 ttmm -35.91 -69.11 0.11 Allowed 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 117.568 2.432 . . . . 0.57 117.568 -152.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -133.85 93.25 3.08 Favored 'General case' 1 C--N 1.447 4.828 0 N-CA-C 102.52 -3.141 . . . . 0.57 102.52 178.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.34 154.64 40.01 Favored 'General case' 0 CA--C 1.597 2.753 0 CA-C-N 110.819 -2.9 . . . . 1.2 104.631 162.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 m -131.38 53.77 12.61 Favored Pre-proline 0 N--CA 1.517 2.92 0 C-N-CA 126.857 2.063 . . . . 0.57 113.546 -3.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -95.12 -170.39 0.19 Allowed 'Trans proline' 0 C--N 1.412 3.881 0 N-CA-C 105.919 -2.377 . . . . 0.57 105.919 160.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.086 ' HB3' ' CB ' ' A' ' 310' ' ' ASN 0.483 0.8 OUTLIER -34.11 84.42 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 O-C-N 127.566 3.042 . . . . 0.57 115.465 170.526 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.527 ' HB2' ' HE1' ' A' ' 309' ' ' MET . 12.0 t-20 -161.62 29.42 0.13 Allowed 'General case' 0 CA--C 1.502 -0.891 1 O-C-N 131.342 5.401 . . . . 0.57 106.375 164.498 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.503 ' HB2' HD12 ' A' ' 131' ' ' LEU . 45.8 p90 -31.19 -54.79 0.23 Allowed 'General case' 0 CA--C 1.596 2.721 0 C-N-CA 129.025 2.93 . . . . 0.57 115.712 -166.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.4 pt -51.85 -55.02 10.73 Favored 'Isoleucine or valine' 0 C--N 1.393 2.483 0 CA-C-N 108.563 -3.926 . . . . 0.57 108.043 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.511 HD21 HG12 ' A' ' 63' ' ' VAL . 3.7 mt -73.09 -11.4 60.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.591 -1.318 . . . . 0.57 113.027 -171.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.518 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -79.46 -54.31 6.04 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 116.08 -2.248 . . . . 0.57 105.302 169.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.408 HD21 ' C ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -168.65 130.98 1.34 Allowed 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 129.092 2.957 . . . . 0.57 105.472 170.316 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 81' ' ' VAL . 1.8 tp -74.65 -31.21 61.87 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 129.995 3.318 . . . . 0.57 115.501 39.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.514 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . -49.91 76.65 0.0 OUTLIER 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 119.893 3.294 . . . . 0.57 119.893 -171.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' LEU . 67.4 t -143.95 -41.43 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.758 0 CA-C-O 125.716 2.674 . . . . 0.57 110.764 166.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.45 -82.65 0.15 Allowed 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 111.197 -2.728 . . . . 0.57 105.079 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.423 ' OD1' ' HA ' ' A' ' 80' ' ' ALA . 10.7 p-10 -15.39 -54.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 118.963 2.949 . . . . 0.91 118.963 159.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.1 tp -49.17 -49.5 42.3 Favored 'General case' 0 C--N 1.414 3.393 1 O-C-N 129.179 4.049 . . . . 0.57 114.476 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . 0.295 8.8 t80 -75.85 -20.56 58.02 Favored 'General case' 0 CA--C 1.553 1.086 1 CA-C-N 107.05 -4.614 . . . . 0.57 112.28 -173.998 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.489 ' SD ' ' HA ' ' A' ' 296' ' ' LYS . 31.6 mtt -60.79 -35.11 75.63 Favored 'General case' 0 C--N 1.371 1.506 0 CA-C-O 126.246 2.927 . . . . 0.57 110.927 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.07 -33.46 63.88 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.406 0 CA-C-N 108.422 -3.99 . . . . 0.57 108.91 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -159.39 79.24 0.74 Allowed 'General case' 0 N--CA 1.518 2.939 0 C-N-CA 116.166 -2.213 . . . . 0.57 110.375 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.83 -139.53 17.16 Favored Glycine 0 C--N 1.375 2.738 0 CA-C-O 122.553 1.085 . . . . 0.57 115.499 -21.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 32.3 -122.83 0.23 Allowed Glycine 1 CA--C 1.625 6.95 0 CA-C-N 113.091 -1.554 . . . . 0.57 112.645 160.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -59.11 -55.89 29.27 Favored 'General case' 0 C--O 1.19 -2.048 0 CA-C-O 124.033 1.873 . . . . 0.57 109.727 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.5 m -46.85 -26.77 1.04 Allowed 'General case' 0 N--CA 1.413 -2.29 0 C-N-CA 129.407 3.083 . . . . 0.57 113.576 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 m -156.85 11.79 0.24 Allowed 'General case' 0 CA--C 1.586 2.336 0 C-N-CA 114.208 -2.997 . . . . 0.57 112.036 -172.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 1.063 ' CA ' ' HB3' ' A' ' 98' ' ' SER . 2.6 m -168.75 45.42 0.04 OUTLIER 'General case' 0 C--O 1.258 1.548 0 C-N-CA 115.225 -2.59 . . . . 0.57 106.206 -173.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.1 tt -166.32 -54.41 0.03 OUTLIER 'General case' 0 C--O 1.188 -2.174 0 O-C-N 118.567 -2.583 . . . . 0.57 106.098 169.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -71.25 -53.92 12.68 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 109.101 -3.681 . . . . 0.57 107.971 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 1.058 ' O ' ' HB2' ' A' ' 98' ' ' SER . 6.2 m -151.71 104.17 3.01 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 115.431 -2.224 . . . . 0.57 105.117 -169.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 1.063 ' HB3' ' CA ' ' A' ' 94' ' ' THR . 3.7 t 146.8 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 120.28 1.4 . . . . 0.57 111.848 -168.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.52 ' HG ' ' SD ' ' A' ' 288' ' ' MET 0.261 0.2 OUTLIER 97.24 -50.61 0.01 OUTLIER 'General case' 0 C--N 1.384 2.1 0 C-N-CA 127.604 2.362 . . . . 0.57 108.298 -176.375 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.59 153.11 48.65 Favored 'General case' 0 CA--C 1.594 2.671 0 N-CA-C 100.741 -3.8 . . . . 0.57 100.741 158.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.694 ' C ' ' HB3' ' A' ' 103' ' ' PHE . . . -93.52 -169.44 38.81 Favored Glycine 1 CA--C 1.581 4.159 0 C-N-CA 130.454 3.883 . . . . 0.57 104.232 -14.022 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 1.536 ' CB ' ' HB2' ' A' ' 103' ' ' PHE 0.426 2.3 m-85 -48.5 -56.17 9.03 Favored 'General case' 0 C--N 1.386 2.159 1 C-N-CA 131.939 4.095 . . . . 0.57 112.979 -0.433 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 1.536 ' HB2' ' CB ' ' A' ' 102' ' ' TYR . 87.8 t80 118.89 -154.1 0.0 OUTLIER 'General case' 0 N--CA 1.416 -2.155 1 C-N-CA 132.449 4.3 . . . . 0.57 103.577 5.678 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 1.07 HG23 ' HA ' ' A' ' 103' ' ' PHE . 59.0 t 121.58 -140.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.251 1.159 0 CA-C-O 128.177 3.846 . . . . 0.57 110.711 -23.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 1.241 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 65.5 t80 85.43 -132.51 0.01 OUTLIER 'General case' 0 CA--C 1.566 1.58 1 N-CA-C 99.856 -4.127 . . . . 0.57 99.856 -163.021 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 105' ' ' PHE . . . -81.38 -70.63 1.33 Allowed Glycine 0 C--N 1.381 3.059 0 C-N-CA 125.13 1.347 . . . . 0.57 113.587 17.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.78 -103.88 0.0 OUTLIER 'Cis proline' 0 N--CA 1.491 1.372 0 N-CA-C 118.107 2.311 . . . . 0.57 118.107 17.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 92.1 m -71.34 106.16 3.77 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 116.628 -2.029 . . . . 0.57 110.739 -135.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.419 ' H ' ' HG3' ' A' ' 183' ' ' MET . . . 60.62 56.99 21.24 Favored Glycine 0 N--CA 1.513 3.776 0 O-C-N 125.648 1.842 . . . . 0.57 113.818 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 1.289 ' CB ' ' SG ' ' A' ' 187' ' ' CYS 2.498 4.8 p 123.29 -65.04 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 117.018 2.229 . . . . 0.57 117.018 172.314 46.484 -114.486 -163.867 89.287 1.262 105.41 89.81 84.215 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.794 ' OD1' ' HE2' ' A' ' 105' ' ' PHE . 0.6 OUTLIER -108.46 45.19 1.04 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 126.956 3.265 . . . . 0.57 105.712 -1.267 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.8 tt -73.66 -60.7 2.13 Favored 'General case' 0 C--N 1.377 1.801 0 CA-C-N 109.32 -3.582 . . . . 0.57 104.034 165.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.763 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 1.3 mp0 -37.78 -83.71 0.01 OUTLIER 'General case' 0 C--O 1.168 -3.185 0 O-C-N 128.837 3.835 . . . . 0.91 112.149 -171.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.81 -15.26 62.03 Favored Glycine 1 CA--C 1.589 4.661 0 CA-C-N 108.573 -3.921 . . . . 0.57 115.216 -170.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -83.44 -100.11 0.05 OUTLIER 'General case' 0 C--O 1.259 1.558 0 N-CA-C 103.51 -2.774 . . . . 0.57 103.51 167.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -46.66 -48.67 19.96 Favored 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 127.312 2.882 . . . . 0.57 114.598 -166.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.763 ' HB3' ' O ' ' A' ' 113' ' ' GLU . . . -63.91 8.61 0.09 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 115.995 1.85 . . . . 0.57 115.995 -175.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.63 ' HA ' H173 ' A' ' 400' ' ' RET . 65.3 p -136.85 -35.7 0.71 Allowed 'General case' 0 C--N 1.383 2.028 0 CA-C-O 126.429 3.014 . . . . 0.57 108.415 171.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.467 ' HA ' HD12 ' A' ' 123' ' ' ILE . 1.4 tp -64.55 -39.61 94.08 Favored 'General case' 0 N--CA 1.396 -3.132 0 CA-C-N 109.432 -3.531 . . . . 0.57 106.017 -174.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.737 ' HA3' ' H11' ' A' ' 400' ' ' RET . . . -75.29 50.5 2.4 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 126.88 2.181 . . . . 0.57 111.496 162.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 122' ' ' GLU . . . -174.22 -112.92 0.3 Allowed Glycine 0 CA--C 1.532 1.105 2 C-N-CA 132.613 4.911 . . . . 0.57 101.359 165.039 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -14.02 -83.7 0.0 OUTLIER 'General case' 0 C--O 1.174 -2.889 0 O-C-N 128.401 3.06 . . . . 0.91 111.395 -177.205 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 119' ' ' LEU . 33.4 mt -63.68 -34.4 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 N-CA-C 118.0 2.593 . . . . 0.57 118.0 -170.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . 0.267 . . -55.88 -45.75 78.49 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 115.496 -2.482 . . . . 0.57 114.595 165.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.78 -15.19 49.36 Favored 'General case' 0 C--N 1.385 2.128 0 CA-C-N 110.103 -3.226 . . . . 0.57 111.714 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.447 ' C ' ' H ' ' A' ' 128' ' ' LEU . 1.1 t90 -89.22 -34.99 16.45 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 113.167 -1.833 . . . . 0.57 110.776 174.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . 0.334 7.1 t -54.83 -11.47 0.62 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 116.907 -1.917 . . . . 0.57 112.317 163.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 126' ' ' TRP 0.29 10.3 tp -67.95 -2.86 8.29 Favored 'General case' 0 N--CA 1.534 3.748 0 N-CA-C 120.89 3.663 . . . . 0.57 120.89 -156.499 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.6 p -64.51 -29.8 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.816 1 CA-C-N 108.013 -4.176 . . . . 0.57 102.51 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 77' ' ' LEU . 17.6 t -81.58 14.96 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.805 0 O-C-N 119.225 -2.172 . . . . 0.57 110.828 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.186 ' O ' ' CD2' ' A' ' 136' ' ' TYR . 5.6 tt -119.26 -22.42 7.13 Favored 'General case' 0 N--CA 1.432 -1.327 1 C-N-CA 134.111 4.964 . . . . 0.57 111.982 163.388 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 1.224 ' O ' ' HB3' ' A' ' 136' ' ' TYR . . . -60.24 -37.71 81.21 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-O 125.604 2.621 . . . . 0.57 109.515 171.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 133' ' ' ILE . 10.5 pt -86.53 60.29 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.259 1.589 0 CA-C-N 109.707 -3.406 . . . . 0.57 107.621 170.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.857 ' H ' ' CB ' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -178.23 -88.18 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.791 1.237 . . . . 0.91 109.434 167.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 1.354 ' O ' ' CD2' ' A' ' 136' ' ' TYR . 4.2 ttp85 -55.62 77.74 0.0 OUTLIER 'General case' 0 C--N 1.384 2.084 0 CA-C-N 121.372 1.896 . . . . 1.2 110.596 163.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 1.354 ' CD2' ' O ' ' A' ' 135' ' ' ARG 0.362 0.1 OUTLIER 160.01 -111.57 0.0 OUTLIER 'General case' 0 C--O 1.261 1.7 0 N-CA-C 105.108 -2.182 . . . . 0.57 105.108 -128.908 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.003 HG23 ' HB2' ' A' ' 140' ' ' CYS . 8.3 p -89.41 54.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.428 3.983 0 N-CA-C 106.21 -1.774 . . . . 0.57 106.21 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.558 HG23 ' HE3' ' A' ' 245' ' ' LYS . 4.3 p -64.41 -30.97 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.931 0 CA-C-O 124.375 2.036 . . . . 0.57 111.125 155.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.7 ' O ' ' HB2' ' A' ' 140' ' ' CYS . 78.3 t -135.31 -107.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.011 1 N-CA-C 96.777 -5.268 . . . . 0.57 96.777 178.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 1.003 ' HB2' HG23 ' A' ' 137' ' ' VAL 2.475 34.5 m -173.41 -52.18 0.01 OUTLIER 'General case' 0 CA--C 1.597 2.774 0 CA-C-N 121.502 1.955 . . . . 0.57 108.834 -173.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.559 ' CG ' ' HB2' ' A' ' 225' ' ' GLN 0.346 0.0 OUTLIER 47.54 83.78 0.21 Allowed Pre-proline 0 N--CA 1.52 3.032 0 O-C-N 127.081 2.738 . . . . 0.57 105.623 -154.041 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . 0.252 9.0 Cg_endo -63.0 124.4 13.92 Favored 'Trans proline' 0 CA--C 1.587 3.157 0 CA-C-O 116.991 -1.337 . . . . 0.57 113.907 -150.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 5.1 mpp? 62.34 -24.27 0.05 Allowed 'General case' 0 CA--C 1.557 1.23 0 O-C-N 127.824 3.203 . . . . 0.57 113.168 170.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.5 m 81.14 -61.63 0.21 Allowed 'General case' 0 CA--C 1.585 2.301 0 C-N-CA 129.151 2.981 . . . . 0.57 111.942 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.257 40.2 t30 -165.2 -144.55 0.07 Allowed 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 114.652 -2.594 . . . . 0.57 108.371 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -58.13 -36.23 72.64 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 113.409 -3.186 . . . . 0.57 110.745 165.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -137.25 -172.84 3.3 Favored 'General case' 0 C--N 1.373 1.629 1 O-C-N 130.734 5.021 . . . . 1.2 107.645 160.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -93.07 120.27 33.18 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 127.963 3.289 . . . . 0.57 105.171 -38.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -105.87 -19.44 10.25 Favored Glycine 0 N--CA 1.504 3.201 0 O-C-N 127.153 2.783 . . . . 0.57 107.107 -177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 150' ' ' GLU . 2.3 mp0 -62.04 70.89 0.01 OUTLIER 'General case' 0 N--CA 1.394 -3.261 0 CA-C-N 112.048 -2.076 . . . . 0.91 113.731 154.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . 0.257 3.4 m-20 -42.6 -46.43 4.94 Favored 'General case' 0 N--CA 1.512 2.663 0 C-N-CA 123.926 0.89 . . . . 0.57 112.693 -155.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . 0.304 2.0 p-80 -62.32 -140.78 0.0 OUTLIER 'General case' 0 CA--C 1.582 2.203 0 N-CA-C 115.948 1.833 . . . . 0.57 115.948 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.416 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . 62.68 -90.5 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 CA-C-O 124.026 1.87 . . . . 0.57 112.759 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.439 HG12 ' N ' ' A' ' 155' ' ' MET . 0.2 OUTLIER -65.33 -50.59 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 O-C-N 119.125 -2.234 . . . . 0.57 110.684 -175.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.439 ' N ' HG12 ' A' ' 154' ' ' ILE . 11.6 ptt? -126.44 63.88 1.26 Allowed 'General case' 0 C--O 1.27 2.167 0 CA-C-N 111.812 -2.449 . . . . 0.57 114.0 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 153' ' ' ALA . . . 81.97 -142.91 22.78 Favored Glycine 2 CA--C 1.617 6.41 0 O-C-N 117.719 -3.113 . . . . 0.57 107.027 -11.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.255 17.6 m -65.79 -36.93 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 114.074 1.139 . . . . 0.57 114.074 -174.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.39 58.66 4.2 Favored 'General case' 0 N--CA 1.401 -2.921 0 O-C-N 127.49 2.994 . . . . 0.57 107.038 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.505 ' CD2' ' HB2' ' A' ' 132' ' ' ALA . 86.4 t80 -163.84 -75.18 0.04 OUTLIER 'General case' 0 CA--C 1.478 -1.824 0 C-N-CA 128.125 2.57 . . . . 0.57 107.635 170.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -65.84 -44.79 84.44 Favored 'General case' 0 CA--C 1.578 2.023 0 C-N-CA 127.816 2.446 . . . . 0.57 109.54 -178.667 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.16 29.9 0.22 Allowed 'General case' 0 N--CA 1.527 3.415 0 CA-C-N 113.567 -1.652 . . . . 0.57 112.365 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 160' ' ' THR . 93.9 t -127.93 -60.27 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.6 2.868 0 N-CA-C 101.203 -3.628 . . . . 0.57 101.203 167.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . 0.253 86.8 mtp -64.67 -40.99 96.36 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 122.887 1.327 . . . . 0.57 109.341 -167.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.03 97.42 11.16 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 118.002 -1.479 . . . . 0.57 111.602 144.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.623 ' C ' ' H ' ' A' ' 167' ' ' CYS . 13.5 tp -134.37 -6.54 2.59 Favored 'General case' 0 N--CA 1.404 -2.739 0 O-C-N 129.08 3.988 . . . . 0.57 111.288 154.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.537 ' HB3' ' HE1' ' A' ' 265' ' ' TRP . . . -66.1 15.11 0.03 OUTLIER 'General case' 1 N--CA 1.544 4.274 0 CA-C-O 127.455 3.502 . . . . 0.57 112.997 166.707 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.623 ' H ' ' C ' ' A' ' 165' ' ' LEU . 3.5 m -59.01 4.0 0.03 OUTLIER 'General case' 0 C--O 1.257 1.463 0 CA-C-N 109.745 -3.389 . . . . 0.57 111.933 168.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 166' ' ' ALA . . . -75.39 -22.32 57.56 Favored 'General case' 0 CA--C 1.572 1.806 0 CA-C-O 117.284 -1.341 . . . . 0.57 107.71 174.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.847 ' HB2' ' SD ' ' A' ' 207' ' ' MET . . . -65.88 -51.21 49.13 Favored Pre-proline 0 C--O 1.212 -0.91 0 N-CA-C 116.846 2.165 . . . . 0.57 116.846 173.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 169' ' ' ALA 0.477 14.5 Cg_exo -32.19 -60.96 0.17 Allowed 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.493 2.129 . . . . 0.57 115.725 166.121 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.485 ' CD ' ' O ' ' A' ' 167' ' ' CYS . 2.8 Cg_exo -51.37 -93.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.187 0 N-CA-C 121.084 3.455 . . . . 0.57 121.084 153.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 172' ' ' LEU . 13.2 mt -69.13 -40.88 78.01 Favored 'General case' 1 N--CA 1.552 4.655 0 CA-C-O 125.876 2.751 . . . . 0.57 114.532 -157.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 38.2 t -60.75 -40.5 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 117.34 -3.35 . . . . 0.57 106.983 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.7 -33.64 57.71 Favored Glycine 1 CA--C 1.596 5.118 0 CA-C-N 112.4 -2.182 . . . . 0.57 111.979 -166.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -62.18 -34.57 76.68 Favored 'General case' 0 N--CA 1.52 3.054 1 O-C-N 130.01 4.006 . . . . 0.57 104.507 169.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.89 25.74 0.44 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 112.397 -3.721 . . . . 0.57 111.369 175.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -126.78 24.69 6.49 Favored 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 122.526 1.155 . . . . 1.2 107.95 162.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -167.17 67.92 0.09 Allowed 'General case' 0 C--N 1.373 1.596 0 CA-C-N 111.997 -2.365 . . . . 0.57 107.651 -164.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 1.336 HD11 ' CD2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -90.74 175.21 3.82 Favored Pre-proline 0 C--N 1.37 1.48 0 C-N-CA 130.933 3.693 . . . . 0.57 103.914 -5.237 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.409 ' HA ' ' HB ' ' A' ' 179' ' ' ILE . 5.3 Cg_exo -53.96 118.61 0.3 Allowed 'Cis proline' 0 C--O 1.279 2.548 0 N-CA-C 115.765 1.41 . . . . 0.57 115.765 -15.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.643 ' O ' ' HB3' ' A' ' 185' ' ' CYS . 0.2 OUTLIER -74.55 125.62 29.02 Favored 'General case' 0 C--N 1.382 1.99 0 C-N-CA 116.601 -2.04 . . . . 0.91 106.413 -163.007 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 1.065 ' HA2' ' CB ' ' A' ' 187' ' ' CYS . . . -85.32 41.21 3.05 Favored Glycine 1 CA--C 1.612 6.133 1 C-N-CA 113.519 -4.181 . . . . 0.57 116.851 -169.748 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.419 ' HG3' ' H ' ' A' ' 109' ' ' GLY . 73.3 mtm -152.69 -50.52 0.1 Allowed 'General case' 0 CA--C 1.595 2.695 0 C-N-CA 128.23 2.612 . . . . 0.57 111.627 168.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -66.19 -33.17 75.16 Favored 'General case' 0 C--N 1.394 2.539 1 C-N-CA 108.807 -5.157 . . . . 0.57 111.764 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.888 ' SG ' ' O ' ' A' ' 189' ' ' ILE . 52.2 t -72.91 -22.8 60.68 Favored 'General case' 0 CA--C 1.482 -1.671 0 O-C-N 127.155 2.784 . . . . 0.57 112.057 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.918 ' O ' ' SG ' ' A' ' 187' ' ' CYS 0.262 0.7 OUTLIER 86.61 -53.37 0.06 Allowed 'General case' 0 CA--C 1.606 3.125 0 C-N-CA 129.556 3.142 . . . . 0.57 110.715 -159.975 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 1.289 ' SG ' ' CB ' ' A' ' 110' ' ' CYS 2.476 2.1 p -158.43 42.06 0.26 Allowed 'General case' 0 C--O 1.251 1.17 0 CA-C-O 125.173 2.416 . . . . 0.57 111.141 168.101 84.215 89.81 -163.867 105.41 1.262 89.287 -114.486 46.484 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.494 ' H ' ' HB3' ' A' ' 185' ' ' CYS . . . 62.69 170.44 1.19 Allowed Glycine 0 N--CA 1.515 3.933 1 C-N-CA 112.073 -4.87 . . . . 0.57 109.901 -144.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.888 ' O ' ' SG ' ' A' ' 185' ' ' CYS 0.275 5.2 pt -74.48 158.03 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.435 0 CA-C-N 122.345 3.073 . . . . 0.57 108.269 21.531 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.628 ' O ' ' HB3' ' A' ' 191' ' ' TYR . 16.7 t70 -153.04 -134.83 0.05 Allowed 'General case' 0 CA--C 1.561 1.39 1 C-N-CA 133.412 4.685 . . . . 0.91 105.614 6.108 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 1.336 ' CD2' HD11 ' A' ' 179' ' ' ILE . 54.8 t80 82.65 38.59 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.307 -1.77 . . . . 0.57 113.862 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -98.18 -132.59 0.23 Allowed 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 110.689 -2.96 . . . . 0.57 107.018 157.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.557 80.4 p 73.39 -122.14 0.0 OUTLIER Pre-proline 0 CA--C 1.577 2.003 0 O-C-N 128.298 3.499 . . . . 0.57 101.732 -162.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 195' ' ' HIS . 0.5 OUTLIER -40.99 115.35 0.35 Allowed 'Trans proline' 0 N--CA 1.421 -2.757 0 N-CA-C 118.931 2.627 . . . . 0.57 118.931 171.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 1.299 ' HB3' ' OG1' ' A' ' 198' ' ' THR . 49.1 m-70 -136.98 75.89 1.56 Allowed 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 125.72 1.888 . . . . 0.57 108.18 -7.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -55.64 -22.71 24.09 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-O 125.814 2.721 . . . . 0.91 116.463 170.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.73 -68.16 0.6 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 111.66 -2.518 . . . . 0.91 107.417 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' THR . . . . . 1.299 ' OG1' ' HB3' ' A' ' 195' ' ' HIS . 82.5 p -68.06 -18.43 64.68 Favored 'General case' 0 CA--C 1.614 3.44 1 O-C-N 129.95 4.531 . . . . 0.57 116.742 -169.212 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -119.52 56.23 0.94 Allowed 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 123.315 1.531 . . . . 0.57 110.361 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -73.97 -13.95 60.96 Favored 'General case' 0 CA--C 1.587 2.383 0 CA-C-N 111.466 -2.606 . . . . 0.57 109.868 166.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -53.98 -111.12 0.0 OUTLIER 'General case' 0 CA--C 1.628 3.954 0 N-CA-C 105.638 -1.986 . . . . 0.91 105.638 157.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 58.8 m -75.63 90.88 2.82 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-O 122.035 0.921 . . . . 0.57 113.229 -168.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -176.19 -128.76 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 109.903 -3.317 . . . . 0.57 103.937 168.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.22 150.79 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.444 0 O-C-N 127.131 2.769 . . . . 0.57 107.736 137.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 13.3 pt -92.97 3.78 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 N-CA-C 103.665 -2.717 . . . . 0.57 103.665 -2.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.454 ' O ' HG12 ' A' ' 209' ' ' VAL . 0.1 OUTLIER -51.71 -33.54 34.9 Favored 'General case' 0 C--N 1.376 1.759 0 N-CA-C 118.0 2.593 . . . . 0.57 118.0 -159.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 207' ' ' MET . . . . . 1.608 ' HG3' ' C3 ' ' A' ' 400' ' ' RET . 28.8 mmt -59.51 -27.75 66.45 Favored 'General case' 0 N--CA 1.421 -1.925 0 O-C-N 124.159 0.912 . . . . 0.57 111.154 -174.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.55 ' CB ' ' HB3' ' A' ' 269' ' ' ALA . 74.3 t80 -92.44 -47.14 7.31 Favored 'General case' 0 C--N 1.39 2.334 0 C-N-CA 117.583 -1.647 . . . . 0.57 110.552 155.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.857 HG13 ' H ' ' A' ' 211' ' ' HIS 0.337 3.4 p 38.4 -103.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 124.786 2.231 . . . . 0.57 111.786 -162.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.539 ' H ' HG13 ' A' ' 209' ' ' VAL . 11.3 m -129.93 3.7 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 127.855 2.462 . . . . 0.57 110.785 155.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.857 ' H ' HG13 ' A' ' 209' ' ' VAL . 8.7 t60 -44.57 -65.25 0.54 Allowed 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 112.337 -2.21 . . . . 0.57 112.796 174.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -81.94 47.3 1.09 Allowed 'General case' 0 CA--C 1.604 3.047 0 CA-C-O 125.043 2.354 . . . . 0.57 111.845 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 22.1 mm -96.0 -5.02 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 124.946 2.307 . . . . 0.57 106.77 162.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.452 HG13 ' HD3' ' A' ' 215' ' ' PRO 0.302 1.3 pt -31.15 -57.72 0.36 Allowed Pre-proline 0 N--CA 1.492 1.637 0 CA-C-O 115.234 -2.317 . . . . 0.57 114.109 167.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.452 ' HD3' HG13 ' A' ' 214' ' ' ILE . 14.6 Cg_endo -75.65 -4.16 14.86 Favored 'Trans proline' 0 C--N 1.384 2.4 0 CA-C-N 125.338 2.942 . . . . 0.57 115.102 -171.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.42 -64.46 1.18 Allowed 'General case' 0 CA--C 1.585 2.326 0 O-C-N 120.136 -1.602 . . . . 0.57 106.73 165.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . 0.361 5.1 tt -65.93 -46.93 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.604 3.046 0 CA-C-N 112.656 -2.066 . . . . 0.57 110.914 -153.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.13 -41.9 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 122.031 2.196 . . . . 0.57 107.6 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.437 HG23 ' HA ' ' A' ' 220' ' ' PHE . 23.9 mm -75.34 149.09 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.441 -3.227 0 CA-C-O 112.286 -3.721 . . . . 0.57 102.588 -176.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' PHE . . . . . 0.724 ' CE2' ' HG2' ' A' ' 135' ' ' ARG . 1.7 t80 -87.48 -26.42 23.23 Favored 'General case' 0 C--O 1.199 -1.564 1 C-N-CA 134.718 5.207 . . . . 0.57 107.926 1.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.439 ' C ' ' H ' ' A' ' 223' ' ' TYR 0.277 28.5 p90 -52.26 -38.21 57.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 126.575 2.422 . . . . 0.57 112.289 -165.07 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . 0.335 30.2 p -63.75 13.97 0.02 OUTLIER 'General case' 0 N--CA 1.392 -3.355 1 O-C-N 129.151 4.032 . . . . 0.57 118.357 -159.621 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.449 ' HB2' ' HB2' ' A' ' 226' ' ' LEU 0.303 0.1 OUTLIER -89.47 -9.15 51.16 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 129.242 3.017 . . . . 0.57 107.167 -172.497 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.65 -56.1 5.01 Favored Glycine 0 N--CA 1.396 -3.989 0 N-CA-C 107.824 -2.11 . . . . 0.57 107.824 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.559 ' HB2' ' CG ' ' A' ' 141' ' ' LYS . 37.8 tp60 -75.73 -23.27 56.03 Favored 'General case' 0 C--N 1.377 1.799 0 O-C-N 120.96 -1.317 . . . . 0.57 109.154 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 223' ' ' TYR . 3.4 mm? -87.73 9.33 21.96 Favored 'General case' 0 C--O 1.202 -1.4 0 O-C-N 128.048 3.343 . . . . 0.57 108.718 177.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 15.1 t -106.26 41.87 0.21 Allowed 'Isoleucine or valine' 1 CA--C 1.632 4.105 1 N-CA-C 99.887 -4.116 . . . . 0.57 99.887 163.361 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -170.02 39.09 0.02 OUTLIER 'General case' 0 C--N 1.41 3.234 0 C-N-CA 125.552 1.541 . . . . 0.57 109.481 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.557 HG21 HG11 ' A' ' 138' ' ' VAL . 6.6 m -165.47 152.72 10.55 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 104.766 -2.309 . . . . 0.57 104.766 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 254' ' ' VAL 0.251 34.3 m 46.33 -64.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 128.648 3.717 . . . . 0.57 116.605 -169.212 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.468 ' NZ ' ' OE2' ' A' ' 232' ' ' GLU . 15.8 ttpp -57.07 -32.62 66.43 Favored 'General case' 0 CA--C 1.584 2.287 0 O-C-N 126.008 2.067 . . . . 0.57 113.675 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 2.9 mp0 -88.13 111.64 21.81 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.641 -1.614 . . . . 0.91 106.641 165.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -60.63 -9.31 3.69 Favored 'General case' 0 C--O 1.202 -1.396 0 C-N-CA 113.809 -3.156 . . . . 0.57 113.227 166.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 232' ' ' GLU . . . -60.05 31.93 0.01 OUTLIER 'General case' 0 C--N 1.36 1.045 0 N-CA-C 116.495 2.035 . . . . 0.57 116.495 158.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -169.02 163.61 11.32 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 107.953 -1.128 . . . . 0.57 107.953 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 71.76 -51.53 0.69 Allowed 'General case' 0 N--CA 1.485 1.309 1 C-N-CA 134.281 5.032 . . . . 0.57 109.974 175.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -42.11 -92.55 0.0 OUTLIER 'General case' 0 N--CA 1.402 -2.861 0 O-C-N 128.22 3.45 . . . . 0.57 111.813 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.41 ' H ' ' CD ' ' A' ' 238' ' ' GLN . 0.7 OUTLIER -54.71 -36.75 65.03 Favored 'General case' 0 C--N 1.377 1.793 0 CA-C-N 113.11 -1.859 . . . . 0.57 109.408 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' A' ' 240' ' ' SER 0.292 0.3 OUTLIER -110.28 78.24 1.11 Allowed 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 125.081 2.372 . . . . 0.91 105.629 -169.456 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.994 ' OG ' ' HA ' ' A' ' 251' ' ' THR . 88.6 p 160.98 -23.05 0.0 OUTLIER 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 109.451 -3.522 . . . . 0.57 107.005 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 1.042 ' O ' ' CG2' ' A' ' 242' ' ' THR 0.321 . . -61.81 -32.48 72.79 Favored 'General case' 0 N--CA 1.514 2.743 0 CA-C-O 123.039 1.399 . . . . 0.57 113.541 158.409 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 242' ' ' THR . . . . . 1.042 ' CG2' ' O ' ' A' ' 241' ' ' ALA 0.363 9.1 t 170.37 42.56 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.536 0 C-N-CA 116.192 -2.203 . . . . 0.57 106.672 -178.594 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . 0.254 15.4 m -149.52 134.09 17.62 Favored 'General case' 0 CA--C 1.587 2.396 1 CA-C-O 128.874 4.178 . . . . 0.57 109.959 168.465 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? 85.78 -45.95 0.06 Allowed 'General case' 1 C--N 1.435 4.299 1 CA-C-N 105.037 -5.529 . . . . 0.57 109.604 166.97 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.558 ' HE3' HG23 ' A' ' 138' ' ' VAL . 10.0 pttm -132.13 -174.66 3.5 Favored 'General case' 0 C--O 1.271 2.185 0 CA-C-N 112.703 -2.044 . . . . 0.57 111.677 -171.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 309' ' ' MET . . . -56.27 145.53 26.45 Favored 'General case' 0 CA--C 1.591 2.52 0 CA-C-N 109.84 -3.345 . . . . 0.57 107.985 170.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 1.28 ' O ' ' CG2' ' A' ' 250' ' ' VAL 0.445 0.0 OUTLIER -81.41 -123.34 0.02 OUTLIER 'General case' 0 C--O 1.204 -1.334 0 O-C-N 127.057 2.723 . . . . 0.91 109.396 -148.72 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.472 ' H ' ' CG ' ' A' ' 247' ' ' GLU . 3.6 ttpm? -36.14 -30.19 0.02 OUTLIER 'General case' 0 C--N 1.345 0.39 0 C-N-CA 128.885 2.874 . . . . 0.57 118.213 -173.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.16 -39.23 19.67 Favored 'General case' 0 CA--C 1.571 1.783 0 C-N-CA 115.025 -2.67 . . . . 0.91 107.706 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 1.28 ' CG2' ' O ' ' A' ' 247' ' ' GLU . 33.7 m -64.92 -17.26 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.357 0 CA-C-N 112.33 -2.214 . . . . 0.57 109.169 169.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.994 ' HA ' ' OG ' ' A' ' 240' ' ' SER . 1.1 m -68.03 -44.85 75.51 Favored 'General case' 0 C--N 1.401 2.827 1 C-N-CA 109.864 -4.734 . . . . 0.57 112.518 160.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -59.03 -22.65 61.03 Favored 'General case' 0 N--CA 1.395 -3.176 0 N-CA-C 116.121 1.897 . . . . 1.2 116.121 -167.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.437 ' HG2' ' HB2' ' A' ' 257' ' ' MET . 9.2 ttt -82.36 27.21 0.51 Allowed 'General case' 0 C--N 1.395 2.56 0 CA-C-O 124.988 2.328 . . . . 0.57 111.979 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.406 ' HA ' HG12 ' A' ' 230' ' ' VAL . 9.1 p -65.11 -16.99 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.241 0 CA-C-N 112.552 -2.113 . . . . 0.57 111.819 145.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 3.6 tp -148.0 -35.12 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-O 123.895 1.807 . . . . 0.57 115.835 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 40.5 mm -51.73 -29.58 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.054 0 N-CA-C 115.785 1.772 . . . . 0.57 115.785 162.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' MET . . . . . 1.046 ' SD ' ' HD2' ' A' ' 135' ' ' ARG . 1.7 tpt -41.41 -55.05 2.91 Favored 'General case' 0 C--N 1.393 2.458 0 O-C-N 128.122 3.389 . . . . 0.57 109.025 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.4 t -75.98 -19.51 15.44 Favored 'Isoleucine or valine' 0 C--N 1.363 1.182 0 O-C-N 125.917 2.01 . . . . 0.57 107.246 -160.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . 0.292 86.3 mt -84.99 14.53 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 126.598 1.959 . . . . 0.57 112.454 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -95.7 -32.11 12.91 Favored 'General case' 0 C--O 1.262 1.75 0 C-N-CA 124.893 1.277 . . . . 0.57 107.894 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.497 ' HD2' ' NE ' ' A' ' 135' ' ' ARG . 6.5 p90 -124.71 8.11 8.2 Favored 'General case' 0 C--O 1.258 1.504 0 CA-C-O 117.486 -1.245 . . . . 0.57 111.649 -174.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . 0.352 0.4 OUTLIER -128.61 25.17 5.72 Favored 'General case' 1 N--CA 1.55 4.554 0 CA-C-N 122.803 2.547 . . . . 0.57 111.607 168.542 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . 0.3 16.5 tt -96.73 142.74 13.52 Favored 'Isoleucine or valine' 0 C--O 1.269 2.1 0 N-CA-C 100.927 -3.731 . . . . 0.57 100.927 176.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' CYS . . . . . . . . . . . . . 99.7 m 51.8 -73.65 0.01 OUTLIER 'General case' 0 C--N 1.281 -2.409 1 C-N-CA 133.126 4.571 . . . . 0.57 110.252 -177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' TRP . . . . . 0.837 ' CE3' H181 ' A' ' 400' ' ' RET 0.486 44.0 t-105 -58.16 -53.58 56.63 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 118.378 -2.701 . . . . 0.57 114.115 -167.567 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.574 HD23 ' C ' ' A' ' 266' ' ' LEU . 7.1 tt -44.56 -68.28 0.3 Allowed Pre-proline 0 C--O 1.274 2.375 0 O-C-N 120.807 -1.183 . . . . 0.57 110.626 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 266' ' ' LEU . 94.8 Cg_endo -72.11 4.21 3.43 Favored 'Trans proline' 0 N--CA 1.519 3.008 0 C-N-CA 123.067 2.511 . . . . 0.57 115.487 -173.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.59 -23.58 53.49 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 115.565 -2.454 . . . . 0.57 117.346 -166.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.55 ' HB3' ' CB ' ' A' ' 208' ' ' PHE 0.372 . . -53.02 -35.13 59.08 Favored 'General case' 0 N--CA 1.534 3.742 0 N-CA-C 116.815 2.154 . . . . 0.57 116.815 174.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -72.83 -17.31 78.28 Favored Glycine 1 CA--C 1.603 5.537 0 C-N-CA 117.644 -2.217 . . . . 0.57 111.459 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 24.0 t -82.82 -43.24 18.6 Favored 'Isoleucine or valine' 0 C--O 1.267 2.025 0 CA-C-N 112.995 -1.603 . . . . 0.57 109.228 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -68.51 -41.34 80.1 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-O 125.619 2.628 . . . . 0.57 115.981 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -44.51 -56.98 3.87 Favored 'General case' 0 C--O 1.277 2.547 0 CA-C-N 111.925 -2.398 . . . . 0.57 110.322 169.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -129.14 93.43 3.58 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 116.234 -2.186 . . . . 0.57 106.926 170.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 16.5 tt -157.7 150.96 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.578 0 CA-C-O 123.44 1.591 . . . . 0.57 108.088 7.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -168.01 51.36 0.05 Allowed 'General case' 0 CA--C 1.592 2.559 0 C-N-CA 128.677 2.791 . . . . 0.57 109.422 162.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . 0.289 15.1 p -162.82 138.8 7.18 Favored 'General case' 0 CA--C 1.58 2.107 0 N-CA-C 101.272 -3.603 . . . . 0.57 101.272 -177.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 42.28 -178.63 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.491 0 O-C-N 127.659 3.1 . . . . 0.57 117.655 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . 0.308 0.5 OUTLIER 131.96 -57.65 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 112.079 -2.328 . . . . 0.57 106.312 165.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 176.03 106.7 0.2 Allowed Glycine 0 N--CA 1.415 -2.709 2 O-C-N 130.015 4.572 . . . . 0.57 102.965 171.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . 0.308 1.9 m -54.4 145.3 18.5 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 112.225 -1.988 . . . . 0.57 108.08 -174.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASP . . . . . . . . . . . . . 11.4 t70 94.87 -78.02 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 105.806 -1.924 . . . . 0.91 105.806 -171.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -88.01 87.13 7.24 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 114.381 -2.928 . . . . 0.57 106.779 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 81.99 89.35 0.64 Allowed Glycine 0 CA--C 1.46 -3.371 0 CA-C-N 110.076 -3.238 . . . . 0.57 108.919 157.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.96 122.94 9.05 Favored 'Cis proline' 1 C--N 1.417 4.148 0 O-C-N 123.29 1.152 . . . . 0.57 111.306 7.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . 0.272 1.1 pp -112.16 99.04 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.193 1.397 . . . . 0.57 112.081 49.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -94.13 68.14 3.68 Favored 'General case' 0 CA--C 1.585 2.326 0 CA-C-O 123.475 1.607 . . . . 0.57 108.604 -172.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' MET . . . . . 0.52 ' SD ' ' HG ' ' A' ' 99' ' ' LEU . 31.7 mmt -72.7 -32.76 66.0 Favored 'General case' 0 N--CA 1.51 2.531 0 CA-C-N 110.948 -2.842 . . . . 0.57 114.122 -174.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 288' ' ' MET . 1.7 t -23.18 -103.26 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.787 0 CA-C-N 110.804 -2.907 . . . . 0.57 111.293 165.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.483 ' HB ' ' HD3' ' A' ' 291' ' ' PRO 0.286 3.0 mt -69.77 -64.7 1.39 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 119.008 -2.307 . . . . 0.57 113.337 -173.519 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.483 ' HD3' ' HB ' ' A' ' 290' ' ' ILE . 17.1 Cg_exo -50.61 -19.34 4.9 Favored 'Trans proline' 0 N--CA 1.516 2.81 0 C-N-CA 125.049 3.832 . . . . 0.57 117.532 -167.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -103.26 -8.15 20.58 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 120.589 1.541 . . . . 0.57 112.457 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -75.27 -28.74 59.91 Favored 'General case' 0 N--CA 1.518 2.966 0 C-N-CA 113.992 -3.083 . . . . 0.57 114.81 -162.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -74.08 -45.15 51.13 Favored 'General case' 0 C--N 1.379 1.876 0 O-C-N 126.856 2.597 . . . . 0.57 108.998 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.43 ' HB1' ' C12' ' A' ' 400' ' ' RET . . . -71.21 -29.26 64.93 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 102.935 -2.987 . . . . 0.57 102.935 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LYS . . . . . 1.251 ' HG2' ' OH ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -96.42 19.03 12.73 Favored 'General case' 0 C--N 1.353 0.742 1 C-N-CA 108.735 -5.186 . . . . 0.0 109.331 -174.764 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 2.4 m -72.79 -10.13 59.44 Favored 'General case' 0 CA--C 1.575 1.926 0 O-C-N 117.903 -2.998 . . . . 0.57 114.386 157.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' SER . . . . . 0.482 ' HB2' ' SD ' ' A' ' 86' ' ' MET . 46.9 m -44.06 -28.09 0.45 Allowed 'General case' 0 N--CA 1.518 2.974 0 O-C-N 128.939 3.899 . . . . 0.57 112.383 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -57.01 -10.77 1.21 Allowed 'General case' 0 N--CA 1.41 -2.46 0 O-C-N 118.513 -2.617 . . . . 0.57 117.952 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 5.4 t -82.38 76.26 1.04 Allowed 'Isoleucine or valine' 1 N--CA 1.376 -4.159 0 CA-C-O 124.34 2.019 . . . . 0.57 108.706 166.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -73.12 79.65 1.25 Allowed 'General case' 0 C--N 1.404 2.954 0 CA-C-N 113.832 -1.531 . . . . 0.57 107.111 161.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.417 ' HB3' ' HD3' ' A' ' 303' ' ' PRO . 25.1 t-20 -145.53 -63.96 0.02 OUTLIER Pre-proline 0 CA--C 1.578 2.036 0 C-N-CA 125.862 1.665 . . . . 0.57 109.084 173.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 302' ' ' ASN . 29.4 Cg_endo -81.28 -22.01 6.11 Favored 'Trans proline' 0 N--CA 1.422 -2.717 0 C-N-CA 116.755 -1.697 . . . . 0.57 110.202 174.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 53.6 t -51.92 -67.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 114.223 -1.353 . . . . 0.57 109.531 165.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . 0.271 35.3 pt -63.24 -23.68 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.481 1 O-C-N 129.163 4.039 . . . . 0.57 109.251 -172.31 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -54.39 -36.62 64.12 Favored 'General case' 0 C--O 1.255 1.363 0 O-C-N 120.332 -1.48 . . . . 0.57 110.503 -157.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 3.7 mm -95.65 61.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 124.678 1.236 . . . . 0.57 109.791 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' MET . . . . . 1.192 ' O ' ' HG3' ' A' ' 309' ' ' MET . 5.6 mtm -65.72 -91.63 0.01 OUTLIER 'General case' 0 CA--C 1.583 2.218 0 CA-C-N 111.505 -2.589 . . . . 0.57 110.836 171.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' MET . . . . . 1.243 ' SD ' ' N ' ' A' ' 310' ' ' ASN 0.423 0.0 OUTLIER 125.68 -111.43 0.0 OUTLIER 'General case' 0 CA--C 1.464 -2.343 0 C-N-CA 125.804 1.641 . . . . 0.57 112.435 -178.566 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ASN . . . . . 1.243 ' N ' ' SD ' ' A' ' 309' ' ' MET . 24.9 t-20 -71.04 -20.41 62.38 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 116.606 2.076 . . . . 0.57 116.606 -160.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.566 ' N ' ' SD ' ' A' ' 309' ' ' MET . 20.2 mmtm -117.58 28.51 8.4 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 108.937 -3.756 . . . . 0.57 109.528 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 313' ' ' PHE 0.28 30.0 tt0 -125.14 97.36 5.2 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 103.825 -2.657 . . . . 0.57 103.825 148.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 1.078 ' HE2' HG23 ' A' ' 342' ' ' THR 0.325 35.7 t80 90.17 118.11 0.03 OUTLIER 'General case' 0 CA--C 1.597 2.779 0 CA-C-N 113.093 -1.867 . . . . 0.57 106.363 -170.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ARG . . . . . 0.485 HH22 ' CD ' ' A' ' 332' ' ' GLU . 0.0 OUTLIER 64.38 47.48 3.07 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 112.567 -2.106 . . . . 1.2 109.231 -149.342 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 316' ' ' CYS . 26.0 t30 -93.63 -44.46 8.18 Favored 'General case' 0 C--N 1.368 1.39 0 O-C-N 126.005 2.066 . . . . 0.57 112.7 -171.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' CYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 315' ' ' ASN . 4.9 m 71.93 -131.57 0.04 OUTLIER 'General case' 0 CA--C 1.586 2.35 0 N-CA-C 101.073 -3.677 . . . . 0.57 101.073 -165.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' MET . . . . . 0.957 ' HG3' HG23 ' A' ' 318' ' ' VAL 0.444 2.1 tpp -55.2 117.23 3.32 Favored 'General case' 0 N--CA 1.409 -2.523 0 C-N-CA 125.799 1.64 . . . . 0.57 112.893 -159.029 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 1.244 HG11 ' O ' ' A' ' 61' ' ' VAL . 9.5 t 100.97 42.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.926 -1.509 . . . . 0.57 106.926 171.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 3.7 m -66.89 39.52 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 131.342 3.857 . . . . 0.57 114.968 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 5.1 m -137.02 64.55 1.53 Allowed 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 109.261 -3.609 . . . . 0.57 110.842 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 8.7 mt -135.7 172.34 13.16 Favored 'General case' 0 N--CA 1.523 3.221 0 CA-C-N 110.66 -2.973 . . . . 0.57 109.811 -175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 97.3 m -69.73 142.22 53.33 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 113.25 -1.795 . . . . 0.57 112.692 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 326' ' ' ASN . 23.4 p -173.44 -110.41 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.432 0 C-N-CA 112.018 -3.873 . . . . 0.57 110.167 -163.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -134.46 -70.81 0.07 OUTLIER Glycine 1 N--CA 1.606 9.992 0 C-N-CA 128.626 3.012 . . . . 0.57 107.318 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -60.72 -49.89 75.68 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 107.108 -1.441 . . . . 0.57 107.108 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.427 ' HA ' ' SG ' ' A' ' 323' ' ' CYS . 1.5 t30 66.87 126.58 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 126.621 2.451 . . . . 0.57 117.57 155.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -82.88 24.05 10.03 Favored 'Cis proline' 0 C--N 1.386 2.534 0 CA-C-O 127.181 2.909 . . . . 0.57 117.184 -6.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 2.4 tt -143.95 124.57 14.07 Favored 'General case' 0 C--O 1.275 2.399 0 CA-C-N 113.075 -1.875 . . . . 0.57 112.289 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 66.32 -149.88 51.63 Favored Glycine 1 CA--C 1.606 5.763 0 O-C-N 127.583 3.052 . . . . 0.57 108.801 162.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' A' ' 343' ' ' SER . 10.9 m-20 -64.43 113.32 3.57 Favored 'General case' 0 C--O 1.176 -2.796 0 CA-C-O 126.693 3.14 . . . . 0.91 111.618 -32.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -146.0 82.39 1.61 Allowed 'General case' 0 N--CA 1.413 -2.307 1 CA-C-N 107.195 -4.548 . . . . 0.91 108.959 -173.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.842 ' O ' ' CB ' ' A' ' 333' ' ' ALA 0.312 0.8 OUTLIER -58.24 -46.34 86.11 Favored 'General case' 0 C--O 1.205 -1.257 0 CA-C-N 112.641 -2.072 . . . . 0.91 114.72 162.411 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ALA . . . . . 0.842 ' CB ' ' O ' ' A' ' 332' ' ' GLU . . . 132.99 -117.04 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 117.724 -1.59 . . . . 0.57 109.863 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' SER . . . . . 1.326 ' O ' ' CG2' ' A' ' 335' ' ' THR 0.511 90.9 p 58.87 -122.0 1.21 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 110.755 -2.929 . . . . 0.57 111.27 -157.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 335' ' ' THR . . . . . 1.326 ' CG2' ' O ' ' A' ' 334' ' ' SER . 40.7 p 143.16 68.81 0.0 OUTLIER 'General case' 0 N--CA 1.403 -2.822 0 O-C-N 127.982 3.301 . . . . 0.57 108.564 -158.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.785 ' O ' ' HB ' ' A' ' 337' ' ' VAL 0.261 0.2 OUTLIER -135.67 55.9 1.85 Allowed 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 101.967 -3.345 . . . . 0.57 101.967 -168.715 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.967 HG12 ' H ' ' A' ' 338' ' ' SER 0.367 21.9 t 80.04 -129.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 CA-C-N 111.562 -2.563 . . . . 0.57 109.953 177.333 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 338' ' ' SER . . . . . 0.967 ' H ' HG12 ' A' ' 337' ' ' VAL 0.298 5.0 m -78.08 -166.3 0.79 Allowed 'General case' 0 C--N 1.38 1.924 0 N-CA-C 117.025 2.231 . . . . 0.57 117.025 -172.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 339' ' ' LYS . . . . . 0.453 ' C ' ' HE1' ' A' ' 313' ' ' PHE . 2.0 ttpm? -124.82 145.1 49.94 Favored 'General case' 0 C--N 1.416 3.489 0 N-CA-C 107.199 -1.408 . . . . 0.57 107.199 172.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' THR . . . . . 0.969 ' O ' ' CZ ' ' A' ' 313' ' ' PHE . 0.2 OUTLIER -84.27 -172.44 4.17 Favored 'General case' 0 C--O 1.256 1.416 0 C-N-CA 117.293 -1.763 . . . . 0.57 106.963 167.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 342' ' ' THR . 26.8 mm-40 -109.89 74.6 0.9 Allowed 'General case' 0 C--O 1.264 1.867 0 O-C-N 117.236 -3.415 . . . . 0.91 106.932 160.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' THR . . . . . 1.078 HG23 ' HE2' ' A' ' 313' ' ' PHE . 1.3 m -144.0 -101.5 0.11 Allowed 'General case' 0 C--N 1.403 2.893 0 CA-C-O 113.471 -3.157 . . . . 0.57 107.436 34.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' SER . . . . . 0.657 ' HB3' ' HB3' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -79.78 55.56 2.08 Favored 'General case' 0 N--CA 1.397 -3.121 0 O-C-N 128.695 3.747 . . . . 0.57 110.614 -164.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 344' ' ' GLN . . . . . 0.636 ' C ' HG22 ' A' ' 345' ' ' VAL . 35.8 mt-30 -124.59 -165.97 1.45 Allowed 'General case' 0 N--CA 1.406 -2.627 0 CA-C-N 108.802 -3.817 . . . . 0.57 100.965 172.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 1.056 ' O ' HG23 ' A' ' 345' ' ' VAL 0.378 17.7 m 27.72 69.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.249 1.032 0 O-C-N 127.899 3.25 . . . . 0.57 113.438 164.322 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.448 ' HA ' ' N ' ' A' ' 345' ' ' VAL . . . -137.31 131.62 17.61 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 119.25 -2.156 . . . . 0.57 105.367 -12.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.48 135.83 59.64 Favored 'Trans proline' 0 C--N 1.376 1.976 0 N-CA-C 103.487 -3.313 . . . . 0.57 103.487 140.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.805 0 O-C-N 124.589 1.181 . . . . 0.3 . 24.308 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 400' ' ' RET . . . . . 1.608 ' C3 ' ' HG3' ' A' ' 207' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.525 3.306 0 CA-C-O 116.527 -1.701 . . . . 0.57 111.279 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . 0.286 . . -57.24 -82.45 0.01 OUTLIER 'General case' 0 C--O 1.262 1.734 1 O-C-N 131.749 5.656 . . . . 0.57 108.15 176.016 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' A' ' 45' ' ' PHE . . . -33.41 -49.35 0.28 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 119.166 3.024 . . . . 0.57 119.166 169.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.251 ' OH ' ' HG2' ' A' ' 296' ' ' LYS . 1.0 OUTLIER -48.81 -61.8 1.85 Allowed 'General case' 0 N--CA 1.425 -1.68 0 C-N-CA 125.51 1.524 . . . . 0.57 107.826 176.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.4 ' C ' ' SD ' ' A' ' 44' ' ' MET . 7.8 tmm? -65.49 -55.9 15.34 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 123.237 1.494 . . . . 0.57 111.302 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.403 ' HB2' ' HA ' ' A' ' 42' ' ' ALA . 5.5 m-30 -37.63 -37.7 0.23 Allowed 'General case' 0 CA--C 1.476 -1.873 0 C-N-CA 129.299 3.04 . . . . 0.57 116.791 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.1 mt -121.31 -66.67 1.03 Allowed 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 125.241 1.416 . . . . 0.57 111.667 174.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 mp -62.05 -42.53 99.28 Favored 'General case' 0 CA--C 1.602 2.967 0 CA-C-N 113.803 -1.544 . . . . 0.57 109.021 -158.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.404 ' O ' ' HZ ' ' A' ' 56' ' ' PHE . 21.5 mm -101.95 15.15 5.43 Favored 'Isoleucine or valine' 0 C--N 1.381 1.941 0 C-N-CA 118.299 -1.36 . . . . 0.57 114.335 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.1 mmm -81.26 70.57 8.13 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 125.81 2.719 . . . . 0.57 106.328 154.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 tp -174.86 -45.88 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.381 1 CA-C-N 105.72 -5.218 . . . . 0.57 104.39 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.588 ' O ' ' CG ' ' A' ' 56' ' ' PHE . . . -54.04 -61.15 7.44 Favored Glycine 0 N--CA 1.501 3.029 0 O-C-N 118.357 -2.714 . . . . 0.57 111.493 161.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 1.005 ' CD1' ' CD1' ' A' ' 56' ' ' PHE . 42.5 m-85 -72.42 136.93 80.99 Favored Pre-proline 0 C--O 1.198 -1.617 0 N-CA-C 105.431 -2.062 . . . . 0.57 105.431 158.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 56' ' ' PHE 0.443 93.0 Cg_endo -94.05 -3.62 42.04 Favored 'Cis proline' 0 C--N 1.387 2.585 0 N-CA-C 117.5 2.077 . . . . 0.57 117.5 -20.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.3 mt -46.95 -65.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.422 3.733 0 CA-C-N 120.46 1.482 . . . . 0.57 113.642 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 59' ' ' LEU . 0.7 OUTLIER -55.91 -51.18 68.53 Favored 'General case' 0 C--N 1.392 2.413 0 CA-C-N 112.342 -2.208 . . . . 0.57 110.656 166.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 1.005 ' CD1' ' CD1' ' A' ' 52' ' ' PHE 0.34 6.0 m-85 -40.71 -66.41 0.33 Allowed 'General case' 0 CA--C 1.592 2.562 0 CA-C-N 114.897 -1.047 . . . . 0.57 111.046 -172.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.9 tp -62.01 -53.76 51.04 Favored 'General case' 0 C--O 1.255 1.381 0 O-C-N 119.521 -1.987 . . . . 0.57 110.175 176.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.323 0.8 OUTLIER -71.56 -3.06 19.25 Favored 'General case' 0 N--CA 1.405 -2.688 0 O-C-N 125.709 1.881 . . . . 0.57 115.373 -169.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 55' ' ' ASN . 3.5 tp -63.85 -41.21 97.85 Favored 'General case' 0 CA--C 1.586 2.34 0 N-CA-C 100.61 -3.848 . . . . 0.57 100.61 173.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -68.99 -43.32 75.1 Favored 'General case' 0 CA--C 1.588 2.409 0 O-C-N 126.897 2.623 . . . . 0.57 106.316 -165.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.244 ' O ' HG11 ' A' ' 318' ' ' VAL . 74.0 t -52.71 -37.21 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.656 0 O-C-N 127.983 3.302 . . . . 0.57 110.878 176.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.7 p -95.18 -81.37 0.4 Allowed 'General case' 0 CA--C 1.577 1.998 0 C-N-CA 115.499 -2.481 . . . . 0.57 113.365 -171.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.511 HG12 HD21 ' A' ' 76' ' ' LEU 0.389 2.6 m -45.71 -65.84 0.16 Allowed 'Isoleucine or valine' 1 N--CA 1.541 4.084 0 CA-C-N 112.465 -2.152 . . . . 0.57 115.408 -151.239 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 36.5 87.08 0.01 OUTLIER 'General case' 0 C--N 1.386 2.163 0 O-C-N 126.077 2.111 . . . . 0.57 115.648 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 40.07 42.28 1.1 Allowed 'General case' 0 C--O 1.211 -0.922 0 CA-C-O 123.516 1.627 . . . . 0.57 110.66 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.518 ' NZ ' ' O ' ' A' ' 77' ' ' LEU . 62.7 mttm 49.31 82.84 0.04 OUTLIER 'General case' 0 N--CA 1.387 -3.592 0 CA-C-N 112.555 -2.111 . . . . 0.57 110.224 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.473 ' NZ ' HG21 ' A' ' 318' ' ' VAL . 24.8 ttmm -35.91 -69.11 0.11 Allowed 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 117.568 2.432 . . . . 0.57 117.568 -152.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -133.85 93.25 3.08 Favored 'General case' 1 C--N 1.447 4.828 0 N-CA-C 102.52 -3.141 . . . . 0.57 102.52 178.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.34 154.64 40.01 Favored 'General case' 0 CA--C 1.597 2.753 0 CA-C-N 110.819 -2.9 . . . . 1.2 104.631 162.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 m -131.38 53.77 12.61 Favored Pre-proline 0 N--CA 1.517 2.92 0 C-N-CA 126.857 2.063 . . . . 0.57 113.546 -3.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -95.12 -170.39 0.19 Allowed 'Trans proline' 0 C--N 1.412 3.881 0 N-CA-C 105.919 -2.377 . . . . 0.57 105.919 160.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.086 ' HB3' ' CB ' ' A' ' 310' ' ' ASN 0.483 0.8 OUTLIER -34.11 84.42 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 O-C-N 127.566 3.042 . . . . 0.57 115.465 170.526 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.527 ' HB2' ' HE1' ' A' ' 309' ' ' MET . 0.3 OUTLIER -161.62 29.42 0.13 Allowed 'General case' 0 CA--C 1.502 -0.891 1 O-C-N 131.342 5.401 . . . . 0.57 106.375 164.498 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.503 ' HB2' HD12 ' A' ' 131' ' ' LEU . 45.8 p90 -31.19 -54.79 0.23 Allowed 'General case' 0 CA--C 1.596 2.721 0 C-N-CA 129.025 2.93 . . . . 0.57 115.712 -166.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.4 pt -51.85 -55.02 10.73 Favored 'Isoleucine or valine' 0 C--N 1.393 2.483 0 CA-C-N 108.563 -3.926 . . . . 0.57 108.043 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.511 HD21 HG12 ' A' ' 63' ' ' VAL . 3.7 mt -73.09 -11.4 60.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.591 -1.318 . . . . 0.57 113.027 -171.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.518 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -79.46 -54.31 6.04 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 116.08 -2.248 . . . . 0.57 105.302 169.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.408 HD21 ' C ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -168.65 130.98 1.34 Allowed 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 129.092 2.957 . . . . 0.57 105.472 170.316 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 81' ' ' VAL . 1.8 tp -74.65 -31.21 61.87 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 129.995 3.318 . . . . 0.57 115.501 39.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.514 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . -49.91 76.65 0.0 OUTLIER 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 119.893 3.294 . . . . 0.57 119.893 -171.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' LEU . 67.4 t -143.95 -41.43 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.758 0 CA-C-O 125.716 2.674 . . . . 0.57 110.764 166.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.45 -82.65 0.15 Allowed 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 111.197 -2.728 . . . . 0.57 105.079 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.423 ' OD1' ' HA ' ' A' ' 80' ' ' ALA . 10.7 p-10 -15.39 -54.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 118.963 2.949 . . . . 0.91 118.963 159.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.1 tp -49.17 -49.5 42.3 Favored 'General case' 0 C--N 1.414 3.393 1 O-C-N 129.179 4.049 . . . . 0.57 114.476 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . 0.295 8.8 t80 -75.85 -20.56 58.02 Favored 'General case' 0 CA--C 1.553 1.086 1 CA-C-N 107.05 -4.614 . . . . 0.57 112.28 -173.998 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.489 ' SD ' ' HA ' ' A' ' 296' ' ' LYS . 31.6 mtt -60.79 -35.11 75.63 Favored 'General case' 0 C--N 1.371 1.506 0 CA-C-O 126.246 2.927 . . . . 0.57 110.927 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.07 -33.46 63.88 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.406 0 CA-C-N 108.422 -3.99 . . . . 0.57 108.91 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -159.39 79.24 0.74 Allowed 'General case' 0 N--CA 1.518 2.939 0 C-N-CA 116.166 -2.213 . . . . 0.57 110.375 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.83 -139.53 17.16 Favored Glycine 0 C--N 1.375 2.738 0 CA-C-O 122.553 1.085 . . . . 0.57 115.499 -21.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 32.3 -122.83 0.23 Allowed Glycine 1 CA--C 1.625 6.95 0 CA-C-N 113.091 -1.554 . . . . 0.57 112.645 160.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -59.11 -55.89 29.27 Favored 'General case' 0 C--O 1.19 -2.048 0 CA-C-O 124.033 1.873 . . . . 0.57 109.727 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.5 m -46.85 -26.77 1.04 Allowed 'General case' 0 N--CA 1.413 -2.29 0 C-N-CA 129.407 3.083 . . . . 0.57 113.576 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 m -156.85 11.79 0.24 Allowed 'General case' 0 CA--C 1.586 2.336 0 C-N-CA 114.208 -2.997 . . . . 0.57 112.036 -172.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 1.063 ' CA ' ' HB3' ' A' ' 98' ' ' SER . 2.6 m -168.75 45.42 0.04 OUTLIER 'General case' 0 C--O 1.258 1.548 0 C-N-CA 115.225 -2.59 . . . . 0.57 106.206 -173.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.1 tt -166.32 -54.41 0.03 OUTLIER 'General case' 0 C--O 1.188 -2.174 0 O-C-N 118.567 -2.583 . . . . 0.57 106.098 169.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -71.25 -53.92 12.68 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 109.101 -3.681 . . . . 0.57 107.971 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 1.058 ' O ' ' HB2' ' A' ' 98' ' ' SER . 6.2 m -151.71 104.17 3.01 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 115.431 -2.224 . . . . 0.57 105.117 -169.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 1.063 ' HB3' ' CA ' ' A' ' 94' ' ' THR . 3.7 t 146.8 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 120.28 1.4 . . . . 0.57 111.848 -168.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.52 ' HG ' ' SD ' ' A' ' 288' ' ' MET 0.261 0.2 OUTLIER 97.24 -50.61 0.01 OUTLIER 'General case' 0 C--N 1.384 2.1 0 C-N-CA 127.604 2.362 . . . . 0.57 108.298 -176.375 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.59 153.11 48.65 Favored 'General case' 0 CA--C 1.594 2.671 0 N-CA-C 100.741 -3.8 . . . . 0.57 100.741 158.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.694 ' C ' ' HB3' ' A' ' 103' ' ' PHE . . . -93.52 -169.44 38.81 Favored Glycine 1 CA--C 1.581 4.159 0 C-N-CA 130.454 3.883 . . . . 0.57 104.232 -14.022 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 1.536 ' CB ' ' HB2' ' A' ' 103' ' ' PHE 0.426 2.3 m-85 -48.5 -56.17 9.03 Favored 'General case' 0 C--N 1.386 2.159 1 C-N-CA 131.939 4.095 . . . . 0.57 112.979 -0.433 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 1.536 ' HB2' ' CB ' ' A' ' 102' ' ' TYR . 87.8 t80 118.89 -154.1 0.0 OUTLIER 'General case' 0 N--CA 1.416 -2.155 1 C-N-CA 132.449 4.3 . . . . 0.57 103.577 5.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 1.07 HG23 ' HA ' ' A' ' 103' ' ' PHE . 59.0 t 121.58 -140.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.251 1.159 0 CA-C-O 128.177 3.846 . . . . 0.57 110.711 -23.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 1.241 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 65.5 t80 85.43 -132.51 0.01 OUTLIER 'General case' 0 CA--C 1.566 1.58 1 N-CA-C 99.856 -4.127 . . . . 0.57 99.856 -163.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 105' ' ' PHE . . . -81.38 -70.63 1.33 Allowed Glycine 0 C--N 1.381 3.059 0 C-N-CA 125.13 1.347 . . . . 0.57 113.587 17.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.78 -103.88 0.0 OUTLIER 'Cis proline' 0 N--CA 1.491 1.372 0 N-CA-C 118.107 2.311 . . . . 0.57 118.107 17.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 92.1 m -71.34 106.16 3.77 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 116.628 -2.029 . . . . 0.57 110.739 -135.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.419 ' H ' ' HG3' ' A' ' 183' ' ' MET . . . 60.62 56.99 21.24 Favored Glycine 0 N--CA 1.513 3.776 0 O-C-N 125.648 1.842 . . . . 0.57 113.818 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 1.289 ' CB ' ' SG ' ' A' ' 187' ' ' CYS 2.498 4.8 p 123.29 -65.04 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 117.018 2.229 . . . . 0.57 117.018 172.314 46.484 -114.486 -163.867 89.287 1.262 105.41 89.81 84.215 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.794 ' OD1' ' HE2' ' A' ' 105' ' ' PHE . 0.6 OUTLIER -108.46 45.19 1.04 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 126.956 3.265 . . . . 0.57 105.712 -1.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.8 tt -73.66 -60.7 2.13 Favored 'General case' 0 C--N 1.377 1.801 0 CA-C-N 109.32 -3.582 . . . . 0.57 104.034 165.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.763 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 1.3 mp0 -37.78 -83.71 0.01 OUTLIER 'General case' 0 C--O 1.168 -3.185 0 O-C-N 128.837 3.835 . . . . 0.91 112.149 -171.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.81 -15.26 62.03 Favored Glycine 1 CA--C 1.589 4.661 0 CA-C-N 108.573 -3.921 . . . . 0.57 115.216 -170.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -83.44 -100.11 0.05 OUTLIER 'General case' 0 C--O 1.259 1.558 0 N-CA-C 103.51 -2.774 . . . . 0.57 103.51 167.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -46.66 -48.67 19.96 Favored 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 127.312 2.882 . . . . 0.57 114.598 -166.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.763 ' HB3' ' O ' ' A' ' 113' ' ' GLU . . . -63.91 8.61 0.09 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 115.995 1.85 . . . . 0.57 115.995 -175.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.63 ' HA ' H173 ' A' ' 400' ' ' RET . 65.3 p -136.85 -35.7 0.71 Allowed 'General case' 0 C--N 1.383 2.028 0 CA-C-O 126.429 3.014 . . . . 0.57 108.415 171.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.467 ' HA ' HD12 ' A' ' 123' ' ' ILE . 1.4 tp -64.55 -39.61 94.08 Favored 'General case' 0 N--CA 1.396 -3.132 0 CA-C-N 109.432 -3.531 . . . . 0.57 106.017 -174.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.737 ' HA3' ' H11' ' A' ' 400' ' ' RET . . . -75.29 50.5 2.4 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 126.88 2.181 . . . . 0.57 111.496 162.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 122' ' ' GLU . . . -174.22 -112.92 0.3 Allowed Glycine 0 CA--C 1.532 1.105 2 C-N-CA 132.613 4.911 . . . . 0.57 101.359 165.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -14.02 -83.7 0.0 OUTLIER 'General case' 0 C--O 1.174 -2.889 0 O-C-N 128.401 3.06 . . . . 0.91 111.395 -177.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 119' ' ' LEU . 33.4 mt -63.68 -34.4 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 N-CA-C 118.0 2.593 . . . . 0.57 118.0 -170.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . 0.267 . . -55.88 -45.75 78.49 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 115.496 -2.482 . . . . 0.57 114.595 165.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.78 -15.19 49.36 Favored 'General case' 0 C--N 1.385 2.128 0 CA-C-N 110.103 -3.226 . . . . 0.57 111.714 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.447 ' C ' ' H ' ' A' ' 128' ' ' LEU . 1.1 t90 -89.22 -34.99 16.45 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 113.167 -1.833 . . . . 0.57 110.776 174.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . 0.334 7.1 t -54.83 -11.47 0.62 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 116.907 -1.917 . . . . 0.57 112.317 163.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 126' ' ' TRP 0.29 10.3 tp -67.95 -2.86 8.29 Favored 'General case' 0 N--CA 1.534 3.748 0 N-CA-C 120.89 3.663 . . . . 0.57 120.89 -156.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.6 p -64.51 -29.8 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.816 1 CA-C-N 108.013 -4.176 . . . . 0.57 102.51 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 77' ' ' LEU . 17.6 t -81.58 14.96 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.805 0 O-C-N 119.225 -2.172 . . . . 0.57 110.828 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.186 ' O ' ' CD2' ' A' ' 136' ' ' TYR . 5.6 tt -119.26 -22.42 7.13 Favored 'General case' 0 N--CA 1.432 -1.327 1 C-N-CA 134.111 4.964 . . . . 0.57 111.982 163.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 1.224 ' O ' ' HB3' ' A' ' 136' ' ' TYR . . . -60.24 -37.71 81.21 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-O 125.604 2.621 . . . . 0.57 109.515 171.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 133' ' ' ILE . 10.5 pt -86.53 60.29 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.259 1.589 0 CA-C-N 109.707 -3.406 . . . . 0.57 107.621 170.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.857 ' H ' ' CB ' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -178.23 -88.18 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.791 1.237 . . . . 0.91 109.434 167.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 1.354 ' O ' ' CD2' ' A' ' 136' ' ' TYR . 4.2 ttp85 -55.62 77.74 0.0 OUTLIER 'General case' 0 C--N 1.384 2.084 0 CA-C-N 121.372 1.896 . . . . 1.2 110.596 163.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 1.354 ' CD2' ' O ' ' A' ' 135' ' ' ARG 0.362 0.1 OUTLIER 160.01 -111.57 0.0 OUTLIER 'General case' 0 C--O 1.261 1.7 0 N-CA-C 105.108 -2.182 . . . . 0.57 105.108 -128.908 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.003 HG23 ' HB2' ' A' ' 140' ' ' CYS . 8.3 p -89.41 54.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.428 3.983 0 N-CA-C 106.21 -1.774 . . . . 0.57 106.21 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.558 HG23 ' HE3' ' A' ' 245' ' ' LYS . 4.3 p -64.41 -30.97 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.931 0 CA-C-O 124.375 2.036 . . . . 0.57 111.125 155.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.7 ' O ' ' HB2' ' A' ' 140' ' ' CYS . 78.3 t -135.31 -107.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.011 1 N-CA-C 96.777 -5.268 . . . . 0.57 96.777 178.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 1.003 ' HB2' HG23 ' A' ' 137' ' ' VAL 2.475 34.5 m -173.41 -52.18 0.01 OUTLIER 'General case' 0 CA--C 1.597 2.774 0 CA-C-N 121.502 1.955 . . . . 0.57 108.834 -173.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.559 ' CG ' ' HB2' ' A' ' 225' ' ' GLN 0.346 0.0 OUTLIER 47.54 83.78 0.21 Allowed Pre-proline 0 N--CA 1.52 3.032 0 O-C-N 127.081 2.738 . . . . 0.57 105.623 -154.041 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . 0.252 9.0 Cg_endo -63.0 124.4 13.92 Favored 'Trans proline' 0 CA--C 1.587 3.157 0 CA-C-O 116.991 -1.337 . . . . 0.57 113.907 -150.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 5.1 mpp? 62.34 -24.27 0.05 Allowed 'General case' 0 CA--C 1.557 1.23 0 O-C-N 127.824 3.203 . . . . 0.57 113.168 170.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.5 m 81.14 -61.63 0.21 Allowed 'General case' 0 CA--C 1.585 2.301 0 C-N-CA 129.151 2.981 . . . . 0.57 111.942 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.257 40.2 t30 -165.2 -144.55 0.07 Allowed 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 114.652 -2.594 . . . . 0.57 108.371 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -58.13 -36.23 72.64 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 113.409 -3.186 . . . . 0.57 110.745 165.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -137.25 -172.84 3.3 Favored 'General case' 0 C--N 1.373 1.629 1 O-C-N 130.734 5.021 . . . . 1.2 107.645 160.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -93.07 120.27 33.18 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 127.963 3.289 . . . . 0.57 105.171 -38.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.454 ' O ' ' ND2' ' A' ' 151' ' ' ASN . . . -105.87 -19.44 10.25 Favored Glycine 0 N--CA 1.504 3.201 0 O-C-N 127.153 2.783 . . . . 0.57 107.107 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 150' ' ' GLU . 2.3 mp0 -62.04 70.89 0.01 OUTLIER 'General case' 0 N--CA 1.394 -3.261 0 CA-C-N 112.048 -2.076 . . . . 0.91 113.731 154.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.471 ' N ' HD22 ' A' ' 151' ' ' ASN 0.257 0.9 OUTLIER -42.6 -46.43 4.94 Favored 'General case' 0 N--CA 1.512 2.663 0 C-N-CA 123.926 0.89 . . . . 0.57 112.693 -155.188 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . 0.304 2.0 p-80 -62.32 -140.78 0.0 OUTLIER 'General case' 0 CA--C 1.582 2.203 0 N-CA-C 115.948 1.833 . . . . 0.57 115.948 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.416 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . 62.68 -90.5 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 CA-C-O 124.026 1.87 . . . . 0.57 112.759 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.439 HG12 ' N ' ' A' ' 155' ' ' MET . 0.2 OUTLIER -65.33 -50.59 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 O-C-N 119.125 -2.234 . . . . 0.57 110.684 -175.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.439 ' N ' HG12 ' A' ' 154' ' ' ILE . 11.6 ptt? -126.44 63.88 1.26 Allowed 'General case' 0 C--O 1.27 2.167 0 CA-C-N 111.812 -2.449 . . . . 0.57 114.0 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 153' ' ' ALA . . . 81.97 -142.91 22.78 Favored Glycine 2 CA--C 1.617 6.41 0 O-C-N 117.719 -3.113 . . . . 0.57 107.027 -11.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.255 17.6 m -65.79 -36.93 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 114.074 1.139 . . . . 0.57 114.074 -174.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.39 58.66 4.2 Favored 'General case' 0 N--CA 1.401 -2.921 0 O-C-N 127.49 2.994 . . . . 0.57 107.038 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.505 ' CD2' ' HB2' ' A' ' 132' ' ' ALA . 86.4 t80 -163.84 -75.18 0.04 OUTLIER 'General case' 0 CA--C 1.478 -1.824 0 C-N-CA 128.125 2.57 . . . . 0.57 107.635 170.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -65.84 -44.79 84.44 Favored 'General case' 0 CA--C 1.578 2.023 0 C-N-CA 127.816 2.446 . . . . 0.57 109.54 -178.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.16 29.9 0.22 Allowed 'General case' 0 N--CA 1.527 3.415 0 CA-C-N 113.567 -1.652 . . . . 0.57 112.365 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 160' ' ' THR . 93.9 t -127.93 -60.27 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.6 2.868 0 N-CA-C 101.203 -3.628 . . . . 0.57 101.203 167.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . 0.253 86.8 mtp -64.67 -40.99 96.36 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 122.887 1.327 . . . . 0.57 109.341 -167.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.03 97.42 11.16 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 118.002 -1.479 . . . . 0.57 111.602 144.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.623 ' C ' ' H ' ' A' ' 167' ' ' CYS . 13.5 tp -134.37 -6.54 2.59 Favored 'General case' 0 N--CA 1.404 -2.739 0 O-C-N 129.08 3.988 . . . . 0.57 111.288 154.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.537 ' HB3' ' HE1' ' A' ' 265' ' ' TRP . . . -66.1 15.11 0.03 OUTLIER 'General case' 1 N--CA 1.544 4.274 0 CA-C-O 127.455 3.502 . . . . 0.57 112.997 166.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.623 ' H ' ' C ' ' A' ' 165' ' ' LEU . 3.5 m -59.01 4.0 0.03 OUTLIER 'General case' 0 C--O 1.257 1.463 0 CA-C-N 109.745 -3.389 . . . . 0.57 111.933 168.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 166' ' ' ALA . . . -75.39 -22.32 57.56 Favored 'General case' 0 CA--C 1.572 1.806 0 CA-C-O 117.284 -1.341 . . . . 0.57 107.71 174.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.847 ' HB2' ' SD ' ' A' ' 207' ' ' MET . . . -65.88 -51.21 49.13 Favored Pre-proline 0 C--O 1.212 -0.91 0 N-CA-C 116.846 2.165 . . . . 0.57 116.846 173.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 169' ' ' ALA 0.477 14.5 Cg_exo -32.19 -60.96 0.17 Allowed 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.493 2.129 . . . . 0.57 115.725 166.121 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.485 ' CD ' ' O ' ' A' ' 167' ' ' CYS . 2.8 Cg_exo -51.37 -93.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.187 0 N-CA-C 121.084 3.455 . . . . 0.57 121.084 153.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 172' ' ' LEU . 13.2 mt -69.13 -40.88 78.01 Favored 'General case' 1 N--CA 1.552 4.655 0 CA-C-O 125.876 2.751 . . . . 0.57 114.532 -157.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 38.2 t -60.75 -40.5 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 117.34 -3.35 . . . . 0.57 106.983 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.7 -33.64 57.71 Favored Glycine 1 CA--C 1.596 5.118 0 CA-C-N 112.4 -2.182 . . . . 0.57 111.979 -166.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -62.18 -34.57 76.68 Favored 'General case' 0 N--CA 1.52 3.054 1 O-C-N 130.01 4.006 . . . . 0.57 104.507 169.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.89 25.74 0.44 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 112.397 -3.721 . . . . 0.57 111.369 175.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -126.78 24.69 6.49 Favored 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 122.526 1.155 . . . . 1.2 107.95 162.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -167.17 67.92 0.09 Allowed 'General case' 0 C--N 1.373 1.596 0 CA-C-N 111.997 -2.365 . . . . 0.57 107.651 -164.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 1.336 HD11 ' CD2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -90.74 175.21 3.82 Favored Pre-proline 0 C--N 1.37 1.48 0 C-N-CA 130.933 3.693 . . . . 0.57 103.914 -5.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.409 ' HA ' ' HB ' ' A' ' 179' ' ' ILE . 5.3 Cg_exo -53.96 118.61 0.3 Allowed 'Cis proline' 0 C--O 1.279 2.548 0 N-CA-C 115.765 1.41 . . . . 0.57 115.765 -15.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.643 ' O ' ' HB3' ' A' ' 185' ' ' CYS . 0.2 OUTLIER -74.55 125.62 29.02 Favored 'General case' 0 C--N 1.382 1.99 0 C-N-CA 116.601 -2.04 . . . . 0.91 106.413 -163.007 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 1.065 ' HA2' ' CB ' ' A' ' 187' ' ' CYS . . . -85.32 41.21 3.05 Favored Glycine 1 CA--C 1.612 6.133 1 C-N-CA 113.519 -4.181 . . . . 0.57 116.851 -169.748 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.419 ' HG3' ' H ' ' A' ' 109' ' ' GLY . 73.3 mtm -152.69 -50.52 0.1 Allowed 'General case' 0 CA--C 1.595 2.695 0 C-N-CA 128.23 2.612 . . . . 0.57 111.627 168.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -66.19 -33.17 75.16 Favored 'General case' 0 C--N 1.394 2.539 1 C-N-CA 108.807 -5.157 . . . . 0.57 111.764 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.888 ' SG ' ' O ' ' A' ' 189' ' ' ILE . 52.2 t -72.91 -22.8 60.68 Favored 'General case' 0 CA--C 1.482 -1.671 0 O-C-N 127.155 2.784 . . . . 0.57 112.057 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.918 ' O ' ' SG ' ' A' ' 187' ' ' CYS 0.262 0.7 OUTLIER 86.61 -53.37 0.06 Allowed 'General case' 0 CA--C 1.606 3.125 0 C-N-CA 129.556 3.142 . . . . 0.57 110.715 -159.975 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 1.289 ' SG ' ' CB ' ' A' ' 110' ' ' CYS 2.476 2.1 p -158.43 42.06 0.26 Allowed 'General case' 0 C--O 1.251 1.17 0 CA-C-O 125.173 2.416 . . . . 0.57 111.141 168.101 84.215 89.81 -163.867 105.41 1.262 89.287 -114.486 46.484 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.494 ' H ' ' HB3' ' A' ' 185' ' ' CYS . . . 62.69 170.44 1.19 Allowed Glycine 0 N--CA 1.515 3.933 1 C-N-CA 112.073 -4.87 . . . . 0.57 109.901 -144.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.888 ' O ' ' SG ' ' A' ' 185' ' ' CYS 0.275 5.2 pt -74.48 158.03 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.435 0 CA-C-N 122.345 3.073 . . . . 0.57 108.269 21.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.628 ' O ' ' HB3' ' A' ' 191' ' ' TYR . 16.7 t70 -153.04 -134.83 0.05 Allowed 'General case' 0 CA--C 1.561 1.39 1 C-N-CA 133.412 4.685 . . . . 0.91 105.614 6.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 1.336 ' CD2' HD11 ' A' ' 179' ' ' ILE . 54.8 t80 82.65 38.59 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.307 -1.77 . . . . 0.57 113.862 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -98.18 -132.59 0.23 Allowed 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 110.689 -2.96 . . . . 0.57 107.018 157.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.557 80.4 p 73.39 -122.14 0.0 OUTLIER Pre-proline 0 CA--C 1.577 2.003 0 O-C-N 128.298 3.499 . . . . 0.57 101.732 -162.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 195' ' ' HIS . 0.5 OUTLIER -40.99 115.35 0.35 Allowed 'Trans proline' 0 N--CA 1.421 -2.757 0 N-CA-C 118.931 2.627 . . . . 0.57 118.931 171.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 1.299 ' HB3' ' OG1' ' A' ' 198' ' ' THR . 49.1 m-70 -136.98 75.89 1.56 Allowed 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 125.72 1.888 . . . . 0.57 108.18 -7.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -55.64 -22.71 24.09 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-O 125.814 2.721 . . . . 0.91 116.463 170.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.73 -68.16 0.6 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 111.66 -2.518 . . . . 0.91 107.417 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 1.299 ' OG1' ' HB3' ' A' ' 195' ' ' HIS . 82.5 p -68.06 -18.43 64.68 Favored 'General case' 0 CA--C 1.614 3.44 1 O-C-N 129.95 4.531 . . . . 0.57 116.742 -169.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -119.52 56.23 0.94 Allowed 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 123.315 1.531 . . . . 0.57 110.361 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -73.97 -13.95 60.96 Favored 'General case' 0 CA--C 1.587 2.383 0 CA-C-N 111.466 -2.606 . . . . 0.57 109.868 166.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -53.98 -111.12 0.0 OUTLIER 'General case' 0 CA--C 1.628 3.954 0 N-CA-C 105.638 -1.986 . . . . 0.91 105.638 157.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 58.8 m -75.63 90.88 2.82 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-O 122.035 0.921 . . . . 0.57 113.229 -168.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -176.19 -128.76 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 109.903 -3.317 . . . . 0.57 103.937 168.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.22 150.79 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.444 0 O-C-N 127.131 2.769 . . . . 0.57 107.736 137.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 13.3 pt -92.97 3.78 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 N-CA-C 103.665 -2.717 . . . . 0.57 103.665 -2.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.454 ' O ' HG12 ' A' ' 209' ' ' VAL . 0.1 OUTLIER -51.71 -33.54 34.9 Favored 'General case' 0 C--N 1.376 1.759 0 N-CA-C 118.0 2.593 . . . . 0.57 118.0 -159.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 1.608 ' HG3' ' C3 ' ' A' ' 400' ' ' RET . 28.8 mmt -59.51 -27.75 66.45 Favored 'General case' 0 N--CA 1.421 -1.925 0 O-C-N 124.159 0.912 . . . . 0.57 111.154 -174.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.55 ' CB ' ' HB3' ' A' ' 269' ' ' ALA . 74.3 t80 -92.44 -47.14 7.31 Favored 'General case' 0 C--N 1.39 2.334 0 C-N-CA 117.583 -1.647 . . . . 0.57 110.552 155.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.857 HG13 ' H ' ' A' ' 211' ' ' HIS 0.337 3.4 p 38.4 -103.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 124.786 2.231 . . . . 0.57 111.786 -162.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.539 ' H ' HG13 ' A' ' 209' ' ' VAL . 11.3 m -129.93 3.7 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 127.855 2.462 . . . . 0.57 110.785 155.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.857 ' H ' HG13 ' A' ' 209' ' ' VAL . 8.7 t60 -44.57 -65.25 0.54 Allowed 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 112.337 -2.21 . . . . 0.57 112.796 174.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -81.94 47.3 1.09 Allowed 'General case' 0 CA--C 1.604 3.047 0 CA-C-O 125.043 2.354 . . . . 0.57 111.845 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 22.1 mm -96.0 -5.02 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 124.946 2.307 . . . . 0.57 106.77 162.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.452 HG13 ' HD3' ' A' ' 215' ' ' PRO 0.302 1.3 pt -31.15 -57.72 0.36 Allowed Pre-proline 0 N--CA 1.492 1.637 0 CA-C-O 115.234 -2.317 . . . . 0.57 114.109 167.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.452 ' HD3' HG13 ' A' ' 214' ' ' ILE . 14.6 Cg_endo -75.65 -4.16 14.86 Favored 'Trans proline' 0 C--N 1.384 2.4 0 CA-C-N 125.338 2.942 . . . . 0.57 115.102 -171.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.42 -64.46 1.18 Allowed 'General case' 0 CA--C 1.585 2.326 0 O-C-N 120.136 -1.602 . . . . 0.57 106.73 165.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . 0.361 5.1 tt -65.93 -46.93 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.604 3.046 0 CA-C-N 112.656 -2.066 . . . . 0.57 110.914 -153.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.13 -41.9 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 122.031 2.196 . . . . 0.57 107.6 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.437 HG23 ' HA ' ' A' ' 220' ' ' PHE . 23.9 mm -75.34 149.09 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.441 -3.227 0 CA-C-O 112.286 -3.721 . . . . 0.57 102.588 -176.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . 0.724 ' CE2' ' HG2' ' A' ' 135' ' ' ARG . 1.7 t80 -87.48 -26.42 23.23 Favored 'General case' 0 C--O 1.199 -1.564 1 C-N-CA 134.718 5.207 . . . . 0.57 107.926 1.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.439 ' C ' ' H ' ' A' ' 223' ' ' TYR 0.277 28.5 p90 -52.26 -38.21 57.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 126.575 2.422 . . . . 0.57 112.289 -165.07 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . 0.335 30.2 p -63.75 13.97 0.02 OUTLIER 'General case' 0 N--CA 1.392 -3.355 1 O-C-N 129.151 4.032 . . . . 0.57 118.357 -159.621 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.449 ' HB2' ' HB2' ' A' ' 226' ' ' LEU 0.303 0.1 OUTLIER -89.47 -9.15 51.16 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 129.242 3.017 . . . . 0.57 107.167 -172.497 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.65 -56.1 5.01 Favored Glycine 0 N--CA 1.396 -3.989 0 N-CA-C 107.824 -2.11 . . . . 0.57 107.824 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.559 ' HB2' ' CG ' ' A' ' 141' ' ' LYS . 37.8 tp60 -75.73 -23.27 56.03 Favored 'General case' 0 C--N 1.377 1.799 0 O-C-N 120.96 -1.317 . . . . 0.57 109.154 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 223' ' ' TYR . 3.4 mm? -87.73 9.33 21.96 Favored 'General case' 0 C--O 1.202 -1.4 0 O-C-N 128.048 3.343 . . . . 0.57 108.718 177.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 15.1 t -106.26 41.87 0.21 Allowed 'Isoleucine or valine' 1 CA--C 1.632 4.105 1 N-CA-C 99.887 -4.116 . . . . 0.57 99.887 163.361 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -170.02 39.09 0.02 OUTLIER 'General case' 0 C--N 1.41 3.234 0 C-N-CA 125.552 1.541 . . . . 0.57 109.481 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.557 HG21 HG11 ' A' ' 138' ' ' VAL . 6.6 m -165.47 152.72 10.55 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 104.766 -2.309 . . . . 0.57 104.766 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 254' ' ' VAL 0.251 34.3 m 46.33 -64.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 128.648 3.717 . . . . 0.57 116.605 -169.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.468 ' NZ ' ' OE2' ' A' ' 232' ' ' GLU . 15.8 ttpp -57.07 -32.62 66.43 Favored 'General case' 0 CA--C 1.584 2.287 0 O-C-N 126.008 2.067 . . . . 0.57 113.675 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 2.9 mp0 -88.13 111.64 21.81 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.641 -1.614 . . . . 0.91 106.641 165.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -60.63 -9.31 3.69 Favored 'General case' 0 C--O 1.202 -1.396 0 C-N-CA 113.809 -3.156 . . . . 0.57 113.227 166.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 232' ' ' GLU . . . -60.05 31.93 0.01 OUTLIER 'General case' 0 C--N 1.36 1.045 0 N-CA-C 116.495 2.035 . . . . 0.57 116.495 158.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -169.02 163.61 11.32 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 107.953 -1.128 . . . . 0.57 107.953 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 71.76 -51.53 0.69 Allowed 'General case' 0 N--CA 1.485 1.309 1 C-N-CA 134.281 5.032 . . . . 0.57 109.974 175.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -42.11 -92.55 0.0 OUTLIER 'General case' 0 N--CA 1.402 -2.861 0 O-C-N 128.22 3.45 . . . . 0.57 111.813 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.41 ' H ' ' CD ' ' A' ' 238' ' ' GLN . 0.7 OUTLIER -54.71 -36.75 65.03 Favored 'General case' 0 C--N 1.377 1.793 0 CA-C-N 113.11 -1.859 . . . . 0.57 109.408 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' A' ' 240' ' ' SER 0.292 0.3 OUTLIER -110.28 78.24 1.11 Allowed 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 125.081 2.372 . . . . 0.91 105.629 -169.456 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.994 ' OG ' ' HA ' ' A' ' 251' ' ' THR . 88.6 p 160.98 -23.05 0.0 OUTLIER 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 109.451 -3.522 . . . . 0.57 107.005 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 1.042 ' O ' ' CG2' ' A' ' 242' ' ' THR 0.321 . . -61.81 -32.48 72.79 Favored 'General case' 0 N--CA 1.514 2.743 0 CA-C-O 123.039 1.399 . . . . 0.57 113.541 158.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 1.042 ' CG2' ' O ' ' A' ' 241' ' ' ALA 0.363 9.1 t 170.37 42.56 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.536 0 C-N-CA 116.192 -2.203 . . . . 0.57 106.672 -178.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . 0.254 15.4 m -149.52 134.09 17.62 Favored 'General case' 0 CA--C 1.587 2.396 1 CA-C-O 128.874 4.178 . . . . 0.57 109.959 168.465 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? 85.78 -45.95 0.06 Allowed 'General case' 1 C--N 1.435 4.299 1 CA-C-N 105.037 -5.529 . . . . 0.57 109.604 166.97 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.558 ' HE3' HG23 ' A' ' 138' ' ' VAL . 10.0 pttm -132.13 -174.66 3.5 Favored 'General case' 0 C--O 1.271 2.185 0 CA-C-N 112.703 -2.044 . . . . 0.57 111.677 -171.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 309' ' ' MET . . . -56.27 145.53 26.45 Favored 'General case' 0 CA--C 1.591 2.52 0 CA-C-N 109.84 -3.345 . . . . 0.57 107.985 170.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 1.28 ' O ' ' CG2' ' A' ' 250' ' ' VAL 0.445 0.0 OUTLIER -81.41 -123.34 0.02 OUTLIER 'General case' 0 C--O 1.204 -1.334 0 O-C-N 127.057 2.723 . . . . 0.91 109.396 -148.72 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.472 ' H ' ' CG ' ' A' ' 247' ' ' GLU . 3.6 ttpm? -36.14 -30.19 0.02 OUTLIER 'General case' 0 C--N 1.345 0.39 0 C-N-CA 128.885 2.874 . . . . 0.57 118.213 -173.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.16 -39.23 19.67 Favored 'General case' 0 CA--C 1.571 1.783 0 C-N-CA 115.025 -2.67 . . . . 0.91 107.706 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 1.28 ' CG2' ' O ' ' A' ' 247' ' ' GLU . 33.7 m -64.92 -17.26 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.357 0 CA-C-N 112.33 -2.214 . . . . 0.57 109.169 169.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.994 ' HA ' ' OG ' ' A' ' 240' ' ' SER . 1.1 m -68.03 -44.85 75.51 Favored 'General case' 0 C--N 1.401 2.827 1 C-N-CA 109.864 -4.734 . . . . 0.57 112.518 160.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -59.03 -22.65 61.03 Favored 'General case' 0 N--CA 1.395 -3.176 0 N-CA-C 116.121 1.897 . . . . 1.2 116.121 -167.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.437 ' HG2' ' HB2' ' A' ' 257' ' ' MET . 9.2 ttt -82.36 27.21 0.51 Allowed 'General case' 0 C--N 1.395 2.56 0 CA-C-O 124.988 2.328 . . . . 0.57 111.979 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.406 ' HA ' HG12 ' A' ' 230' ' ' VAL . 9.1 p -65.11 -16.99 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.241 0 CA-C-N 112.552 -2.113 . . . . 0.57 111.819 145.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 3.6 tp -148.0 -35.12 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-O 123.895 1.807 . . . . 0.57 115.835 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 40.5 mm -51.73 -29.58 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.054 0 N-CA-C 115.785 1.772 . . . . 0.57 115.785 162.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' MET . . . . . 1.046 ' SD ' ' HD2' ' A' ' 135' ' ' ARG . 1.7 tpt -41.41 -55.05 2.91 Favored 'General case' 0 C--N 1.393 2.458 0 O-C-N 128.122 3.389 . . . . 0.57 109.025 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.4 t -75.98 -19.51 15.44 Favored 'Isoleucine or valine' 0 C--N 1.363 1.182 0 O-C-N 125.917 2.01 . . . . 0.57 107.246 -160.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . 0.292 86.3 mt -84.99 14.53 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 126.598 1.959 . . . . 0.57 112.454 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -95.7 -32.11 12.91 Favored 'General case' 0 C--O 1.262 1.75 0 C-N-CA 124.893 1.277 . . . . 0.57 107.894 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.497 ' HD2' ' NE ' ' A' ' 135' ' ' ARG . 6.5 p90 -124.71 8.11 8.2 Favored 'General case' 0 C--O 1.258 1.504 0 CA-C-O 117.486 -1.245 . . . . 0.57 111.649 -174.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . 0.352 0.4 OUTLIER -128.61 25.17 5.72 Favored 'General case' 1 N--CA 1.55 4.554 0 CA-C-N 122.803 2.547 . . . . 0.57 111.607 168.542 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . 0.3 16.5 tt -96.73 142.74 13.52 Favored 'Isoleucine or valine' 0 C--O 1.269 2.1 0 N-CA-C 100.927 -3.731 . . . . 0.57 100.927 176.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' CYS . . . . . . . . . . . . . 99.7 m 51.8 -73.65 0.01 OUTLIER 'General case' 0 C--N 1.281 -2.409 1 C-N-CA 133.126 4.571 . . . . 0.57 110.252 -177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' TRP . . . . . 0.837 ' CE3' H181 ' A' ' 400' ' ' RET 0.486 44.0 t-105 -58.16 -53.58 56.63 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 118.378 -2.701 . . . . 0.57 114.115 -167.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.574 HD23 ' C ' ' A' ' 266' ' ' LEU . 7.1 tt -44.56 -68.28 0.3 Allowed Pre-proline 0 C--O 1.274 2.375 0 O-C-N 120.807 -1.183 . . . . 0.57 110.626 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 266' ' ' LEU . 94.8 Cg_endo -72.11 4.21 3.43 Favored 'Trans proline' 0 N--CA 1.519 3.008 0 C-N-CA 123.067 2.511 . . . . 0.57 115.487 -173.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.59 -23.58 53.49 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 115.565 -2.454 . . . . 0.57 117.346 -166.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.55 ' HB3' ' CB ' ' A' ' 208' ' ' PHE 0.372 . . -53.02 -35.13 59.08 Favored 'General case' 0 N--CA 1.534 3.742 0 N-CA-C 116.815 2.154 . . . . 0.57 116.815 174.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -72.83 -17.31 78.28 Favored Glycine 1 CA--C 1.603 5.537 0 C-N-CA 117.644 -2.217 . . . . 0.57 111.459 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 24.0 t -82.82 -43.24 18.6 Favored 'Isoleucine or valine' 0 C--O 1.267 2.025 0 CA-C-N 112.995 -1.603 . . . . 0.57 109.228 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -68.51 -41.34 80.1 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-O 125.619 2.628 . . . . 0.57 115.981 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -44.51 -56.98 3.87 Favored 'General case' 0 C--O 1.277 2.547 0 CA-C-N 111.925 -2.398 . . . . 0.57 110.322 169.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -129.14 93.43 3.58 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 116.234 -2.186 . . . . 0.57 106.926 170.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 16.5 tt -157.7 150.96 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.578 0 CA-C-O 123.44 1.591 . . . . 0.57 108.088 7.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -168.01 51.36 0.05 Allowed 'General case' 0 CA--C 1.592 2.559 0 C-N-CA 128.677 2.791 . . . . 0.57 109.422 162.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . 0.289 15.1 p -162.82 138.8 7.18 Favored 'General case' 0 CA--C 1.58 2.107 0 N-CA-C 101.272 -3.603 . . . . 0.57 101.272 -177.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 42.28 -178.63 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.491 0 O-C-N 127.659 3.1 . . . . 0.57 117.655 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . 0.308 0.5 OUTLIER 131.96 -57.65 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 112.079 -2.328 . . . . 0.57 106.312 165.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 176.03 106.7 0.2 Allowed Glycine 0 N--CA 1.415 -2.709 2 O-C-N 130.015 4.572 . . . . 0.57 102.965 171.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . 0.308 1.9 m -54.4 145.3 18.5 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 112.225 -1.988 . . . . 0.57 108.08 -174.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASP . . . . . . . . . . . . . 11.4 t70 94.87 -78.02 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 105.806 -1.924 . . . . 0.91 105.806 -171.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -88.01 87.13 7.24 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 114.381 -2.928 . . . . 0.57 106.779 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 81.99 89.35 0.64 Allowed Glycine 0 CA--C 1.46 -3.371 0 CA-C-N 110.076 -3.238 . . . . 0.57 108.919 157.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.96 122.94 9.05 Favored 'Cis proline' 1 C--N 1.417 4.148 0 O-C-N 123.29 1.152 . . . . 0.57 111.306 7.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . 0.272 1.1 pp -112.16 99.04 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.193 1.397 . . . . 0.57 112.081 49.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -94.13 68.14 3.68 Favored 'General case' 0 CA--C 1.585 2.326 0 CA-C-O 123.475 1.607 . . . . 0.57 108.604 -172.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' MET . . . . . 0.52 ' SD ' ' HG ' ' A' ' 99' ' ' LEU . 31.7 mmt -72.7 -32.76 66.0 Favored 'General case' 0 N--CA 1.51 2.531 0 CA-C-N 110.948 -2.842 . . . . 0.57 114.122 -174.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 288' ' ' MET . 1.7 t -23.18 -103.26 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.787 0 CA-C-N 110.804 -2.907 . . . . 0.57 111.293 165.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.483 ' HB ' ' HD3' ' A' ' 291' ' ' PRO 0.286 3.0 mt -69.77 -64.7 1.39 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 119.008 -2.307 . . . . 0.57 113.337 -173.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.483 ' HD3' ' HB ' ' A' ' 290' ' ' ILE . 17.1 Cg_exo -50.61 -19.34 4.9 Favored 'Trans proline' 0 N--CA 1.516 2.81 0 C-N-CA 125.049 3.832 . . . . 0.57 117.532 -167.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -103.26 -8.15 20.58 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 120.589 1.541 . . . . 0.57 112.457 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -75.27 -28.74 59.91 Favored 'General case' 0 N--CA 1.518 2.966 0 C-N-CA 113.992 -3.083 . . . . 0.57 114.81 -162.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -74.08 -45.15 51.13 Favored 'General case' 0 C--N 1.379 1.876 0 O-C-N 126.856 2.597 . . . . 0.57 108.998 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.43 ' HB1' ' C12' ' A' ' 400' ' ' RET . . . -71.21 -29.26 64.93 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 102.935 -2.987 . . . . 0.57 102.935 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . 1.251 ' HG2' ' OH ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -96.42 19.03 12.73 Favored 'General case' 0 C--N 1.353 0.742 1 C-N-CA 108.735 -5.186 . . . . 0.0 109.331 -174.764 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 2.4 m -72.79 -10.13 59.44 Favored 'General case' 0 CA--C 1.575 1.926 0 O-C-N 117.903 -2.998 . . . . 0.57 114.386 157.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . 0.482 ' HB2' ' SD ' ' A' ' 86' ' ' MET . 46.9 m -44.06 -28.09 0.45 Allowed 'General case' 0 N--CA 1.518 2.974 0 O-C-N 128.939 3.899 . . . . 0.57 112.383 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -57.01 -10.77 1.21 Allowed 'General case' 0 N--CA 1.41 -2.46 0 O-C-N 118.513 -2.617 . . . . 0.57 117.952 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 5.4 t -82.38 76.26 1.04 Allowed 'Isoleucine or valine' 1 N--CA 1.376 -4.159 0 CA-C-O 124.34 2.019 . . . . 0.57 108.706 166.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -73.12 79.65 1.25 Allowed 'General case' 0 C--N 1.404 2.954 0 CA-C-N 113.832 -1.531 . . . . 0.57 107.111 161.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.417 ' HB3' ' HD3' ' A' ' 303' ' ' PRO . 25.1 t-20 -145.53 -63.96 0.02 OUTLIER Pre-proline 0 CA--C 1.578 2.036 0 C-N-CA 125.862 1.665 . . . . 0.57 109.084 173.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 302' ' ' ASN . 29.4 Cg_endo -81.28 -22.01 6.11 Favored 'Trans proline' 0 N--CA 1.422 -2.717 0 C-N-CA 116.755 -1.697 . . . . 0.57 110.202 174.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 53.6 t -51.92 -67.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 114.223 -1.353 . . . . 0.57 109.531 165.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . 0.271 35.3 pt -63.24 -23.68 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.481 1 O-C-N 129.163 4.039 . . . . 0.57 109.251 -172.31 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -54.39 -36.62 64.12 Favored 'General case' 0 C--O 1.255 1.363 0 O-C-N 120.332 -1.48 . . . . 0.57 110.503 -157.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 3.7 mm -95.65 61.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 124.678 1.236 . . . . 0.57 109.791 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' MET . . . . . 1.192 ' O ' ' HG3' ' A' ' 309' ' ' MET . 5.6 mtm -65.72 -91.63 0.01 OUTLIER 'General case' 0 CA--C 1.583 2.218 0 CA-C-N 111.505 -2.589 . . . . 0.57 110.836 171.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' MET . . . . . 1.243 ' SD ' ' N ' ' A' ' 310' ' ' ASN 0.423 0.0 OUTLIER 125.68 -111.43 0.0 OUTLIER 'General case' 0 CA--C 1.464 -2.343 0 C-N-CA 125.804 1.641 . . . . 0.57 112.435 -178.566 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ASN . . . . . 1.243 ' N ' ' SD ' ' A' ' 309' ' ' MET . 24.9 t-20 -71.04 -20.41 62.38 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 116.606 2.076 . . . . 0.57 116.606 -160.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.566 ' N ' ' SD ' ' A' ' 309' ' ' MET . 20.2 mmtm -117.58 28.51 8.4 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 108.937 -3.756 . . . . 0.57 109.528 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 313' ' ' PHE 0.28 30.0 tt0 -125.14 97.36 5.2 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 103.825 -2.657 . . . . 0.57 103.825 148.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 1.078 ' HE2' HG23 ' A' ' 342' ' ' THR 0.325 35.7 t80 90.17 118.11 0.03 OUTLIER 'General case' 0 CA--C 1.597 2.779 0 CA-C-N 113.093 -1.867 . . . . 0.57 106.363 -170.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . 0.485 HH22 ' CD ' ' A' ' 332' ' ' GLU . 0.0 OUTLIER 64.38 47.48 3.07 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 112.567 -2.106 . . . . 1.2 109.231 -149.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 316' ' ' CYS . 26.0 t30 -93.63 -44.46 8.18 Favored 'General case' 0 C--N 1.368 1.39 0 O-C-N 126.005 2.066 . . . . 0.57 112.7 -171.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' CYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 315' ' ' ASN . 4.9 m 71.93 -131.57 0.04 OUTLIER 'General case' 0 CA--C 1.586 2.35 0 N-CA-C 101.073 -3.677 . . . . 0.57 101.073 -165.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' MET . . . . . 0.957 ' HG3' HG23 ' A' ' 318' ' ' VAL 0.444 2.1 tpp -55.2 117.23 3.32 Favored 'General case' 0 N--CA 1.409 -2.523 0 C-N-CA 125.799 1.64 . . . . 0.57 112.893 -159.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 1.244 HG11 ' O ' ' A' ' 61' ' ' VAL . 9.5 t 100.97 42.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.926 -1.509 . . . . 0.57 106.926 171.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 3.7 m -66.89 39.52 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 131.342 3.857 . . . . 0.57 114.968 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 5.1 m -137.02 64.55 1.53 Allowed 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 109.261 -3.609 . . . . 0.57 110.842 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 8.7 mt -135.7 172.34 13.16 Favored 'General case' 0 N--CA 1.523 3.221 0 CA-C-N 110.66 -2.973 . . . . 0.57 109.811 -175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 97.3 m -69.73 142.22 53.33 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 113.25 -1.795 . . . . 0.57 112.692 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 326' ' ' ASN . 23.4 p -173.44 -110.41 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.432 0 C-N-CA 112.018 -3.873 . . . . 0.57 110.167 -163.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -134.46 -70.81 0.07 OUTLIER Glycine 1 N--CA 1.606 9.992 0 C-N-CA 128.626 3.012 . . . . 0.57 107.318 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -60.72 -49.89 75.68 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 107.108 -1.441 . . . . 0.57 107.108 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.427 ' HA ' ' SG ' ' A' ' 323' ' ' CYS . 1.5 t30 66.87 126.58 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 126.621 2.451 . . . . 0.57 117.57 155.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -82.88 24.05 10.03 Favored 'Cis proline' 0 C--N 1.386 2.534 0 CA-C-O 127.181 2.909 . . . . 0.57 117.184 -6.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 2.4 tt -143.95 124.57 14.07 Favored 'General case' 0 C--O 1.275 2.399 0 CA-C-N 113.075 -1.875 . . . . 0.57 112.289 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 66.32 -149.88 51.63 Favored Glycine 1 CA--C 1.606 5.763 0 O-C-N 127.583 3.052 . . . . 0.57 108.801 162.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' A' ' 343' ' ' SER . 10.9 m-20 -64.43 113.32 3.57 Favored 'General case' 0 C--O 1.176 -2.796 0 CA-C-O 126.693 3.14 . . . . 0.91 111.618 -32.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -146.0 82.39 1.61 Allowed 'General case' 0 N--CA 1.413 -2.307 1 CA-C-N 107.195 -4.548 . . . . 0.91 108.959 -173.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.842 ' O ' ' CB ' ' A' ' 333' ' ' ALA 0.312 0.8 OUTLIER -58.24 -46.34 86.11 Favored 'General case' 0 C--O 1.205 -1.257 0 CA-C-N 112.641 -2.072 . . . . 0.91 114.72 162.411 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . 0.842 ' CB ' ' O ' ' A' ' 332' ' ' GLU . . . 132.99 -117.04 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 117.724 -1.59 . . . . 0.57 109.863 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 1.326 ' O ' ' CG2' ' A' ' 335' ' ' THR 0.511 90.9 p 58.87 -122.0 1.21 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 110.755 -2.929 . . . . 0.57 111.27 -157.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 1.326 ' CG2' ' O ' ' A' ' 334' ' ' SER . 40.7 p 143.16 68.81 0.0 OUTLIER 'General case' 0 N--CA 1.403 -2.822 0 O-C-N 127.982 3.301 . . . . 0.57 108.564 -158.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.785 ' O ' ' HB ' ' A' ' 337' ' ' VAL 0.261 0.2 OUTLIER -135.67 55.9 1.85 Allowed 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 101.967 -3.345 . . . . 0.57 101.967 -168.715 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.967 HG12 ' H ' ' A' ' 338' ' ' SER 0.367 21.9 t 80.04 -129.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 CA-C-N 111.562 -2.563 . . . . 0.57 109.953 177.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . 0.967 ' H ' HG12 ' A' ' 337' ' ' VAL 0.298 5.0 m -78.08 -166.3 0.79 Allowed 'General case' 0 C--N 1.38 1.924 0 N-CA-C 117.025 2.231 . . . . 0.57 117.025 -172.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . 0.453 ' C ' ' HE1' ' A' ' 313' ' ' PHE . 2.0 ttpm? -124.82 145.1 49.94 Favored 'General case' 0 C--N 1.416 3.489 0 N-CA-C 107.199 -1.408 . . . . 0.57 107.199 172.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . 0.969 ' O ' ' CZ ' ' A' ' 313' ' ' PHE . 0.2 OUTLIER -84.27 -172.44 4.17 Favored 'General case' 0 C--O 1.256 1.416 0 C-N-CA 117.293 -1.763 . . . . 0.57 106.963 167.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 342' ' ' THR . 26.8 mm-40 -109.89 74.6 0.9 Allowed 'General case' 0 C--O 1.264 1.867 0 O-C-N 117.236 -3.415 . . . . 0.91 106.932 160.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 1.078 HG23 ' HE2' ' A' ' 313' ' ' PHE . 1.3 m -144.0 -101.5 0.11 Allowed 'General case' 0 C--N 1.403 2.893 0 CA-C-O 113.471 -3.157 . . . . 0.57 107.436 34.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . 0.657 ' HB3' ' HB3' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -79.78 55.56 2.08 Favored 'General case' 0 N--CA 1.397 -3.121 0 O-C-N 128.695 3.747 . . . . 0.57 110.614 -164.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . 0.636 ' C ' HG22 ' A' ' 345' ' ' VAL . 10.0 mt-30 -124.59 -165.97 1.45 Allowed 'General case' 0 N--CA 1.406 -2.627 0 CA-C-N 108.802 -3.817 . . . . 0.57 100.965 172.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 1.056 ' O ' HG23 ' A' ' 345' ' ' VAL 0.378 17.7 m 27.72 69.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.249 1.032 0 O-C-N 127.899 3.25 . . . . 0.57 113.438 164.322 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.448 ' HA ' ' N ' ' A' ' 345' ' ' VAL . . . -137.31 131.62 17.61 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 119.25 -2.156 . . . . 0.57 105.367 -12.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.48 135.83 59.64 Favored 'Trans proline' 0 C--N 1.376 1.976 0 N-CA-C 103.487 -3.313 . . . . 0.57 103.487 140.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.805 0 O-C-N 124.589 1.181 . . . . 0.3 . 24.308 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' RET . . . . . 1.608 ' C3 ' ' HG3' ' A' ' 207' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_